| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | H1-10 ZNF609 KAT6A NSD1 BRD3 HMGA1 MED1 ATAD2 NPM2 HP1BP3 H1-8 TNRC18 SCML2 L3MBTL1 H1-3 EXO1 NUCKS1 SMARCC1 H1-1 ELK4 TOP2A BAHCC1 | 8.17e-08 | 739 | 157 | 22 | GO:0003682 |
| GeneOntologyMolecularFunction | microtubule binding | KIF23 MAP6 CETN1 DLGAP5 NUMA1 CKAP5 KIF4A TERF1 CCDC66 KIF3B NAV3 GOLGA8B CEP57 GOLGA8A | 1.55e-07 | 308 | 157 | 14 | GO:0008017 |
| GeneOntologyMolecularFunction | tubulin binding | KIF23 MAP6 CETN1 DLGAP5 NUMA1 CKAP5 KIF4A TERF1 CCDC66 KIF3B NAV3 GOLGA8B CEP57 GOLGA8A | 7.54e-06 | 428 | 157 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | nucleosome binding | 1.23e-05 | 98 | 157 | 7 | GO:0031491 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 1.39e-04 | 100 | 157 | 6 | GO:0030527 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.84e-04 | 67 | 157 | 5 | GO:0031492 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 4.93e-04 | 20 | 157 | 3 | GO:0008301 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.75e-04 | 303 | 157 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | antigen binding | IGHV1-69-2 IGHV1-58 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV7-4-1 | 7.76e-04 | 190 | 157 | 7 | GO:0003823 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H1-10 ARID4B HIRIP3 ARID4A KAT6A DLGAP5 TOPBP1 NSD1 BRD3 HMGA1 MED1 ATAD2 IFI16 TERF1 NPM2 HP1BP3 PHF2 H1-8 L3MBTL1 FAM50A TET1 H1-3 MKI67 NUCKS1 SMARCC1 H1-1 BAHCC1 | 4.31e-09 | 999 | 152 | 27 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromosome organization | H1-10 KIF23 SETX KAT6A DLGAP5 NUMA1 TOPBP1 KIF4A HMGA1 TERF1 H1-8 KIF3B H1-3 XRN1 EXO1 SMARCC1 GOLGA8B H1-1 GOLGA8A SLX4 TOP2A GNL3 | 6.76e-09 | 686 | 152 | 22 | GO:0051276 |
| GeneOntologyBiologicalProcess | chromatin organization | H1-10 ARID4B HIRIP3 ARID4A KAT6A TOPBP1 NSD1 BRD3 HMGA1 ATAD2 IFI16 NPM2 HP1BP3 PHF2 H1-8 L3MBTL1 FAM50A TET1 H1-3 MKI67 NUCKS1 SMARCC1 H1-1 BAHCC1 | 4.15e-08 | 896 | 152 | 24 | GO:0006325 |
| GeneOntologyBiologicalProcess | sexual reproduction | PDE3A SETX ARID4B ARID4A NUMA1 TOPBP1 HMGA1 TERF1 NPM2 H1-8 GK2 FAM50A STAU2 MKI67 XRN1 EXO1 NANOS3 GOLGA8B H1-1 RAI14 SPAG17 CEP57 GOLGA8A SLX4 TOP2A SLC26A6 AFF4 | 1.08e-06 | 1312 | 152 | 27 | GO:0019953 |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.10e-06 | 142 | 152 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | PDE3A NUMA1 TOPBP1 TERF1 NPM2 H1-8 MKI67 XRN1 EXO1 GOLGA8B GOLGA8A SLX4 TOP2A | 2.04e-06 | 350 | 152 | 13 | GO:0051321 |
| GeneOntologyBiologicalProcess | nuclear division | PDE3A KIF23 DLGAP5 NUMA1 TOPBP1 KIF4A TERF1 NPM2 KIF3B L3MBTL1 MKI67 GOLGA8B GOLGA8A SLX4 TOP2A | 6.04e-06 | 512 | 152 | 15 | GO:0000280 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H1-10 ARID4B ARID4A KAT6A NSD1 BRD3 HMGA1 ATAD2 IFI16 NPM2 HP1BP3 PHF2 H1-8 L3MBTL1 TET1 H1-3 SMARCC1 H1-1 | 9.20e-06 | 741 | 152 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.07e-05 | 237 | 152 | 10 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.28e-05 | 242 | 152 | 10 | GO:0098727 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | CUL4B H1-10 SETX RBBP6 ATAD5 TOPBP1 XPC HMGA1 TERF1 NPM2 LIG3 H1-8 H1-3 XRN1 EXO1 NUCKS1 SMARCC1 H1-1 CLSPN SLX4 TOP2A GNL3 | 1.45e-05 | 1081 | 152 | 22 | GO:0006259 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.64e-05 | 249 | 152 | 10 | GO:0065004 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.65e-05 | 151 | 152 | 8 | GO:0007052 | |
| GeneOntologyBiologicalProcess | DNA recombination | H1-10 SETX ATAD5 TOPBP1 LIG3 H1-8 H1-3 EXO1 NUCKS1 H1-1 SLX4 TOP2A | 1.89e-05 | 368 | 152 | 12 | GO:0006310 |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 1.99e-05 | 155 | 152 | 8 | GO:0051053 | |
| GeneOntologyBiologicalProcess | organelle fission | PDE3A KIF23 DLGAP5 NUMA1 TOPBP1 KIF4A TERF1 NPM2 KIF3B L3MBTL1 MKI67 GOLGA8B GOLGA8A SLX4 TOP2A | 2.19e-05 | 571 | 152 | 15 | GO:0048285 |
| GeneOntologyBiologicalProcess | chromosome condensation | 2.70e-05 | 48 | 152 | 5 | GO:0030261 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 3.39e-05 | 122 | 152 | 7 | GO:0006334 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 5.26e-05 | 55 | 152 | 5 | GO:0045910 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | IGHV1-69-2 ATAD5 IGHV1-58 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 EXO1 IGHV7-4-1 | 6.34e-05 | 235 | 152 | 9 | GO:0016064 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 7.58e-05 | 187 | 152 | 8 | GO:1902850 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | H1-10 RBBP6 ATAD5 TERF1 NPM2 LIG3 H1-8 H1-3 XRN1 NUCKS1 SMARCC1 H1-1 SLX4 GNL3 | 7.63e-05 | 564 | 152 | 14 | GO:0051052 |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 8.22e-05 | 12 | 152 | 3 | GO:0000022 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | IGHV1-69-2 ATAD5 IGHV1-58 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 EXO1 IGHV7-4-1 | 8.46e-05 | 244 | 152 | 9 | GO:0019724 |
| GeneOntologyBiologicalProcess | DNA replication | 1.10e-04 | 312 | 152 | 10 | GO:0006260 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | KIF23 DLGAP5 NUMA1 KIF4A KIF3B SMARCC1 GOLGA8B GOLGA8A TOP2A | 1.15e-04 | 254 | 152 | 9 | GO:0000819 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | KIF23 DLGAP5 NUMA1 KIF4A NPM2 KIF3B L3MBTL1 MKI67 GOLGA8B GOLGA8A | 1.22e-04 | 316 | 152 | 10 | GO:0140014 |
| GeneOntologyBiologicalProcess | spindle elongation | 1.35e-04 | 14 | 152 | 3 | GO:0051231 | |
| GeneOntologyBiologicalProcess | cell cycle process | CUL4B PDE3A KIF23 ATAD5 CETN1 DLGAP5 NUMA1 TOPBP1 CKAP5 KIF4A XPC MED1 TERF1 NPM2 KIF3B L3MBTL1 MKI67 SMARCC1 GOLGA8B CLSPN GOLGA8A SLX4 TOP2A TBX1 | 1.41e-04 | 1441 | 152 | 24 | GO:0022402 |
| GeneOntologyBiologicalProcess | formation of extrachromosomal circular DNA | 1.67e-04 | 15 | 152 | 3 | GO:0001325 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere trimming | 1.67e-04 | 15 | 152 | 3 | GO:0090737 | |
| GeneOntologyBiologicalProcess | t-circle formation | 1.67e-04 | 15 | 152 | 3 | GO:0090656 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CUL4B PDE3A KIF23 ATAD5 DLGAP5 NUMA1 TOPBP1 XPC MED1 TERF1 NPM2 KIF3B L3MBTL1 MKI67 SMARCC1 CLSPN TBX1 | 1.69e-04 | 845 | 152 | 17 | GO:0010564 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CUL4B KIF23 ATAD5 DLGAP5 NUMA1 TOPBP1 CKAP5 KIF4A XPC NPM2 KIF3B L3MBTL1 MKI67 SMARCC1 GOLGA8B CLSPN GOLGA8A | 1.92e-04 | 854 | 152 | 17 | GO:1903047 |
| GeneOntologyBiologicalProcess | spindle organization | 2.62e-04 | 224 | 152 | 8 | GO:0007051 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.79e-04 | 78 | 152 | 5 | GO:2000036 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | KIF23 MAP6 CETN1 DLGAP5 NUMA1 CKAP5 BMERB1 KIF4A CCDC66 KIF3B NAV3 GOLGA8B PARD3 SPAG17 GOLGA8A | 2.88e-04 | 720 | 152 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | KIF23 DLGAP5 NUMA1 KIF4A TERF1 KIF3B SMARCC1 GOLGA8B GOLGA8A TOP2A | 3.18e-04 | 356 | 152 | 10 | GO:0098813 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 3.58e-04 | 178 | 152 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 4.16e-04 | 240 | 152 | 8 | GO:0140013 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | CUL4B NOLC1 SETX CKAP5 NCL RPL14 ESF1 NOM1 RBMX2 RPS19BP1 SF3A3 PDCD11 | 4.45e-04 | 515 | 152 | 12 | GO:0022613 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 4.66e-04 | 307 | 152 | 9 | GO:0090068 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CUL4B NOLC1 KIF23 ATAD5 DLGAP5 NUMA1 TOPBP1 CKAP5 KIF4A XPC NPM2 KIF3B L3MBTL1 MKI67 SMARCC1 GOLGA8B CLSPN GOLGA8A | 4.93e-04 | 1014 | 152 | 18 | GO:0000278 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 5.41e-04 | 51 | 152 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 5.45e-04 | 22 | 152 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 5.98e-04 | 92 | 152 | 5 | GO:0090307 | |
| GeneOntologyBiologicalProcess | cell division | KIF23 CETN1 NUMA1 CKAP5 KIF4A TERF1 LIG3 KIF3B GOLGA8B FGF4 PARD3 GOLGA8A TOP2A GNL3 | 6.60e-04 | 697 | 152 | 14 | GO:0051301 |
| GeneOntologyBiologicalProcess | chromosome segregation | KIF23 DLGAP5 NUMA1 KIF4A TERF1 KIF3B MKI67 SMARCC1 GOLGA8B GOLGA8A TOP2A | 6.81e-04 | 465 | 152 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 7.09e-04 | 24 | 152 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | regulation of DNA replication | 7.81e-04 | 147 | 152 | 6 | GO:0006275 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF23 MAP6 CETN1 DLGAP5 NUMA1 CKAP5 BMERB1 KIF4A CCDC66 GK2 KIF3B STAU2 NAV3 GOLGA8B PARD3 SPAG17 GOLGA8A ARHGAP21 | 8.08e-04 | 1058 | 152 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 8.17e-04 | 266 | 152 | 8 | GO:0033044 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 8.57e-04 | 268 | 152 | 8 | GO:1903046 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 8.68e-04 | 150 | 152 | 6 | GO:0000018 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 9.01e-04 | 26 | 152 | 3 | GO:1902455 | |
| GeneOntologyBiologicalProcess | spindle assembly | 9.62e-04 | 153 | 152 | 6 | GO:0051225 | |
| GeneOntologyBiologicalProcess | Golgi localization | 1.01e-03 | 27 | 152 | 3 | GO:0051645 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.01e-03 | 212 | 152 | 7 | GO:0000070 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 ELOA ELOA2 ARID4B ARID4A AFF3 TOPBP1 NSD1 POM121L2 NCL XPC HMGA1 MED1 TERF1 LIG3 SCML2 L3MBTL1 CDK13 RBMX2 TET1 SF3A3 SUGP1 SMARCC1 SLX4 AFF4 | 2.50e-05 | 1377 | 154 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SOX4 H1-10 ARID4B ARID4A KAT6A NSD1 BRD3 XPC HMGA1 MED1 NPM2 HP1BP3 H1-8 SCML2 OTX1 L3MBTL1 PHF20L1 TET1 H1-3 NUCKS1 SMARCC1 H1-1 ELK4 SLX4 TBX1 AFF4 | 2.96e-05 | 1480 | 154 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 5.74e-05 | 56 | 154 | 5 | GO:0008023 | |
| GeneOntologyCellularComponent | microtubule | KIF23 MAP6 NUMA1 CKAP5 KIF4A CCDC66 KIF3B STAU2 NAV3 GOLGA8B SPAG17 CEP57 GOLGA8A | 1.65e-04 | 533 | 154 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | spindle | KIF23 CETN1 DLGAP5 NUMA1 TOPBP1 CKAP5 KIF4A TERF1 KIF3B GOLGA8B PARD3 GOLGA8A | 1.98e-04 | 471 | 154 | 12 | GO:0005819 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV1-69-2 IGHV1-58 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV7-4-1 | 2.34e-04 | 166 | 154 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | Sin3-type complex | 5.45e-04 | 22 | 154 | 3 | GO:0070822 | |
| GeneOntologyCellularComponent | nucleosome | 5.60e-04 | 138 | 154 | 6 | GO:0000786 | |
| GeneOntologyCellularComponent | nuclear chromosome | 6.04e-04 | 254 | 154 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | super elongation complex | 7.93e-04 | 6 | 154 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | spindle pole | 8.29e-04 | 205 | 154 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | nuclear body | NOLC1 SETX RBBP6 ZC3H13 KAT6A AFF3 TOPBP1 IFI16 TERF1 HP1BP3 CDK13 NUFIP2 MKI67 SF3A3 EXO1 GNL3 | 1.05e-03 | 903 | 154 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | fibrillar center | 1.06e-03 | 156 | 154 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | elongin complex | 1.11e-03 | 7 | 154 | 2 | GO:0070449 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.51e-03 | 113 | 154 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.03e-03 | 307 | 154 | 8 | GO:0000793 | |
| MousePheno | abnormal prenatal growth/weight/body size | CUL4B ELOA ZNF609 ELOA2 SASH1 TCOF1 RBBP6 ZC3H13 KAT6A NACA AFF3 CKAP5 KIF4A MED1 LIG3 KIF3B PNPLA1 CDK13 BTBD7 TET1 NUFIP2 XRN1 SUGP1 TMEM131 HADHA PARD3 GNL3 TBX1 AFF4 | 9.07e-06 | 1493 | 116 | 29 | MP:0004196 |
| MousePheno | embryonic growth retardation | CUL4B ELOA ELOA2 SASH1 TCOF1 RBBP6 ZC3H13 NACA MED1 LIG3 CDK13 TET1 XRN1 SUGP1 HADHA PARD3 GNL3 TBX1 AFF4 | 1.56e-05 | 763 | 116 | 19 | MP:0003984 |
| MousePheno | abnormal ear shape | 1.90e-05 | 7 | 116 | 3 | MP:0000022 | |
| MousePheno | prenatal growth retardation | CUL4B ELOA ELOA2 SASH1 TCOF1 RBBP6 ZC3H13 NACA MED1 LIG3 CDK13 BTBD7 TET1 XRN1 SUGP1 HADHA PARD3 GNL3 TBX1 AFF4 | 2.84e-05 | 869 | 116 | 20 | MP:0010865 |
| MousePheno | abnormal embryo development | CUL4B ELOA ELOA2 SASH1 TCOF1 RBBP6 ZC3H13 NACA TOPBP1 CKAP5 NSD1 MED1 LIG3 FREM2 KIF3B CDK13 TET1 XRN1 SUGP1 FGF4 HADHA CLSPN PARD3 GNL3 TBX1 AFF4 | 4.43e-05 | 1370 | 116 | 26 | MP:0001672 |
| MousePheno | abnormal embryonic growth/weight/body size | CUL4B ELOA ZNF609 ELOA2 SASH1 TCOF1 RBBP6 ZC3H13 NACA CKAP5 MED1 LIG3 KIF3B PNPLA1 CDK13 TET1 NUFIP2 XRN1 SUGP1 TMEM131 HADHA PARD3 GNL3 TBX1 AFF4 | 4.86e-05 | 1295 | 116 | 25 | MP:0002088 |
| MousePheno | delayed brain development | 8.75e-05 | 11 | 116 | 3 | MP:0001889 | |
| Domain | H15 | 3.10e-10 | 13 | 144 | 6 | SM00526 | |
| Domain | H15 | 3.10e-10 | 13 | 144 | 6 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 5.40e-10 | 14 | 144 | 6 | IPR005818 | |
| Domain | Linker_histone | 3.11e-08 | 13 | 144 | 5 | PF00538 | |
| Domain | Histone_H5 | 2.44e-05 | 8 | 144 | 3 | IPR005819 | |
| Domain | - | 4.97e-05 | 218 | 144 | 9 | 1.10.10.10 | |
| Domain | MBT | 5.18e-05 | 10 | 144 | 3 | PF02820 | |
| Domain | Mbt | 5.18e-05 | 10 | 144 | 3 | IPR004092 | |
| Domain | RBB1NT | 5.90e-05 | 2 | 144 | 2 | PF08169 | |
| Domain | RBB1NT | 5.90e-05 | 2 | 144 | 2 | IPR012603 | |
| Domain | WHTH_DNA-bd_dom | 1.11e-04 | 242 | 144 | 9 | IPR011991 | |
| Domain | TF_AF4/FMR2 | 3.51e-04 | 4 | 144 | 2 | IPR007797 | |
| Domain | AF-4 | 3.51e-04 | 4 | 144 | 2 | PF05110 | |
| Domain | RNA_pol_II_trans_fac_SIII_A | 5.81e-04 | 5 | 144 | 2 | IPR010684 | |
| Domain | Elongin_A | 5.81e-04 | 5 | 144 | 2 | PF06881 | |
| Domain | Tudor-knot | 8.68e-04 | 6 | 144 | 2 | PF11717 | |
| Domain | Tudor-knot | 8.68e-04 | 6 | 144 | 2 | IPR025995 | |
| Domain | ZF_PHD_1 | 8.85e-04 | 96 | 144 | 5 | PS01359 | |
| Domain | TUDOR | 1.15e-03 | 27 | 144 | 3 | SM00333 | |
| Domain | BRCT_dom | 1.28e-03 | 28 | 144 | 3 | IPR001357 | |
| Domain | Tudor | 1.56e-03 | 30 | 144 | 3 | IPR002999 | |
| Domain | Zinc_finger_PHD-type_CS | 1.59e-03 | 65 | 144 | 4 | IPR019786 | |
| Domain | MBT | 2.05e-03 | 9 | 144 | 2 | SM00561 | |
| Domain | MBT | 2.05e-03 | 9 | 144 | 2 | PS51079 | |
| Domain | Chromo/shadow_dom | 2.07e-03 | 33 | 144 | 3 | IPR000953 | |
| Domain | CHROMO | 2.07e-03 | 33 | 144 | 3 | SM00298 | |
| Domain | TFIIS/CRSP70_N_sub | 2.55e-03 | 10 | 144 | 2 | IPR003617 | |
| Domain | TFS2N | 2.55e-03 | 10 | 144 | 2 | SM00509 | |
| Domain | PHD | 2.70e-03 | 75 | 144 | 4 | PF00628 | |
| Domain | BROMODOMAIN_1 | 2.88e-03 | 37 | 144 | 3 | PS00633 | |
| Domain | BAH | 3.10e-03 | 11 | 144 | 2 | PS51038 | |
| Domain | BAH_dom | 3.10e-03 | 11 | 144 | 2 | IPR001025 | |
| Domain | BAH | 3.10e-03 | 11 | 144 | 2 | SM00439 | |
| Domain | BAH | 3.10e-03 | 11 | 144 | 2 | PF01426 | |
| Domain | Znf_PHD-finger | 3.25e-03 | 79 | 144 | 4 | IPR019787 | |
| Domain | Kinesin_motor_CS | 3.86e-03 | 41 | 144 | 3 | IPR019821 | |
| Domain | BROMODOMAIN_2 | 3.86e-03 | 41 | 144 | 3 | PS50014 | |
| Domain | Bromodomain | 4.14e-03 | 42 | 144 | 3 | IPR001487 | |
| Domain | BROMO | 4.14e-03 | 42 | 144 | 3 | SM00297 | |
| Domain | - | 4.14e-03 | 42 | 144 | 3 | 1.20.920.10 | |
| Domain | Med26 | 4.36e-03 | 13 | 144 | 2 | PF08711 | |
| Domain | - | 4.36e-03 | 13 | 144 | 2 | 1.20.930.10 | |
| Domain | TFIIS_N | 4.36e-03 | 13 | 144 | 2 | PS51319 | |
| Domain | Kinesin-like_fam | 4.42e-03 | 43 | 144 | 3 | IPR027640 | |
| Domain | - | 4.72e-03 | 44 | 144 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.72e-03 | 44 | 144 | 3 | PF00225 | |
| Domain | KISc | 4.72e-03 | 44 | 144 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.72e-03 | 44 | 144 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.72e-03 | 44 | 144 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.72e-03 | 44 | 144 | 3 | PS50067 | |
| Domain | PHD | 4.99e-03 | 89 | 144 | 4 | SM00249 | |
| Domain | TFIIS_N | 5.06e-03 | 14 | 144 | 2 | IPR017923 | |
| Domain | Znf_PHD | 5.39e-03 | 91 | 144 | 4 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 5.66e-03 | 147 | 144 | 5 | IPR011011 | |
| Domain | - | 5.80e-03 | 15 | 144 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 5.80e-03 | 15 | 144 | 2 | SM00501 | |
| Domain | ARID_dom | 5.80e-03 | 15 | 144 | 2 | IPR001606 | |
| Domain | ARID | 5.80e-03 | 15 | 144 | 2 | PS51011 | |
| Domain | ARID | 5.80e-03 | 15 | 144 | 2 | PF01388 | |
| Domain | ZF_PHD_2 | 6.27e-03 | 95 | 144 | 4 | PS50016 | |
| Domain | AT_hook | 6.60e-03 | 16 | 144 | 2 | PF02178 | |
| Domain | Translation_prot_SH3-like | 7.44e-03 | 17 | 144 | 2 | IPR008991 | |
| Domain | AAA | 7.53e-03 | 52 | 144 | 3 | PF00004 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 H1-10 ZNF609 KIF23 SETX ARID4B HIRIP3 TCOF1 ARID4A RBBP6 ATAD5 C19orf53 ZC3H13 DLGAP5 NUMA1 TOPBP1 CKAP5 NSD1 KIF4A NCL BRD3 XPC RPL14 HMGA1 MED1 IFI16 TERF1 SP110 HP1BP3 PHF2 LIG3 SCML2 OTX1 CDK13 NOM1 RBMX2 AHNAK MKI67 SF3A3 EXO1 SMARCC1 PDCD11 NKTR HADHA DDX24 CCDC86 TOP2A JRKL GNL3 | 4.32e-31 | 1294 | 161 | 49 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B NOLC1 H1-10 ELOA EDF1 ZNF609 KIF23 SETX ARID4B ARID4A RBBP6 ATAD5 C19orf53 ZC3H13 ZNF280C DLGAP5 NUMA1 TOPBP1 NSD1 KIF4A NCL HMGA1 MED1 ESF1 HP1BP3 PHF2 LIG3 SCML2 AHNAK STAU2 NUFIP2 MKI67 SF3A3 SUGP1 SMARCC1 PDCD11 DDX24 CCDC86 SLX4 TOP2A GNL3 AFF4 VDAC1 | 3.43e-30 | 954 | 161 | 43 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B NOLC1 H1-10 ELOA KIF23 ARID4B HIRIP3 TCOF1 ARID4A RBBP6 ZC3H13 DLGAP5 NUMA1 CKAP5 NCL BRD3 XPC HMGA1 MED1 ATAD2 IFI16 ESF1 SCML2 FAM13A CDK13 RBMX2 MKI67 EXO1 NUCKS1 SMARCC1 PARD3 DDX24 PRG4 CCDC86 TOP2A VDAC1 | 1.14e-25 | 774 | 161 | 36 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA KIF23 SETX ARID4B HIRIP3 ARID4A ATAD5 ZNF280C KAT6A DLGAP5 NUMA1 TOPBP1 NSD1 KIF4A BRD3 XPC MED1 ATAD2 HP1BP3 PHF2 LIG3 SCML2 PHF20L1 FAM50A RBMX2 MKI67 SMARCC1 DDX24 CCDC86 TOP2A GNL3 AFF4 | 1.83e-24 | 608 | 161 | 32 | 36089195 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ELOA EDF1 KIF23 TCOF1 RBBP6 ATAD5 ZNF280C NACA DLGAP5 NUMA1 CKAP5 KIF4A AASDHPPT NCL RPL14 HMGA1 MED1 ESF1 HP1BP3 LIG3 SCML2 FAM50A AHNAK STAU2 NUFIP2 MKI67 XRN1 SUGP1 NUCKS1 RAI14 ARHGAP21 TOP2A GNL3 AFF4 VDAC1 | 6.42e-23 | 934 | 161 | 36 | 33916271 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 H1-10 ELOA KIF23 ARID4B RBBP6 ATAD5 KAT6A NACA NUMA1 TOPBP1 CKAP5 KIF4A NCL RPL14 MED1 TERF1 ESF1 HP1BP3 LIG3 CDK13 NOM1 STAU2 NEMF NUFIP2 MKI67 XRN1 EXO1 PDCD11 DDX24 CCDC86 TOP2A GNL3 | 1.26e-22 | 759 | 161 | 33 | 35915203 |
| Pubmed | CUL4B NOLC1 H1-10 KIF23 TCOF1 ZC3H13 NUMA1 CKAP5 NSD1 KIF4A NCL RPL14 ATAD2 ESF1 HP1BP3 AHNAK NUFIP2 H1-3 MKI67 XRN1 SMARCC1 PDCD11 H1-1 HADHA DDX24 CCDC86 GNL3 VDAC1 | 4.19e-19 | 653 | 161 | 28 | 22586326 | |
| Pubmed | NOLC1 PDE3A KIF23 SETX HIRIP3 TCOF1 RBBP6 ZC3H13 DLGAP5 NUMA1 TOPBP1 KIF4A NCL MED1 IFI16 FAM13A CDK13 STAU2 NUFIP2 MKI67 NUCKS1 TMEM131 DDX24 TOP2A | 1.59e-17 | 503 | 161 | 24 | 16964243 | |
| Pubmed | EDF1 KIF23 ARID4B HIRIP3 ARID4A ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A BRD3 XPC MED1 ATAD2 PHF2 LIG3 CCDC66 FAM50A AHNAK NUFIP2 XRN1 PIP4K2B RAI14 HADHA CCDC86 VDAC1 | 3.86e-17 | 645 | 161 | 26 | 25281560 | |
| Pubmed | ELOA EDF1 SETX TCOF1 NACA NUMA1 NCL XPC RPL14 HMGA1 MED1 HP1BP3 ANKRD36B PHF2 FAM50A CDK13 NOM1 RBMX2 AHNAK STAU2 NEMF NUFIP2 RPS19BP1 MKI67 SMARCC1 PDCD11 GOLGA8B RAI14 NKTR HADHA PARD3 CCDC86 GNL3 AFF4 VDAC1 | 1.19e-16 | 1371 | 161 | 35 | 36244648 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 ELOA EDF1 SETX TCOF1 MAP6 RBBP6 ZC3H13 NCL BRD3 XPC RPL14 HMGA1 MED1 TERF1 HP1BP3 PHF2 LIG3 RBMX2 XPNPEP3 STAU2 NEMF SF3A3 SUGP1 NUCKS1 SMARCC1 HADHA DDX24 CCDC86 AFF4 VDAC1 | 3.75e-16 | 1082 | 161 | 31 | 38697112 |
| Pubmed | NOLC1 H1-10 TCOF1 NACA DLGAP5 NUMA1 CKAP5 KIF4A NCL RPL14 HMGA1 MED1 HP1BP3 LIG3 NUFIP2 H1-3 MKI67 PIP4K2B HADHA TOP2A | 2.40e-14 | 441 | 161 | 20 | 31239290 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 H1-10 EDF1 TCOF1 RBBP6 ZC3H13 NCL RPL14 ESF1 FAM50A CDK13 NOM1 STAU2 NUFIP2 H1-3 RPS19BP1 XRN1 SF3A3 SUGP1 NUCKS1 PDCD11 DDX24 CCDC86 TOP2A GNL3 | 6.53e-14 | 807 | 161 | 25 | 22681889 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 ELOA KIF23 TCOF1 ZNF280C DLGAP5 NUMA1 KIF4A NCL RPL14 ATAD2 ESF1 AHNAK NUFIP2 MKI67 SF3A3 SUGP1 SMARCC1 PDCD11 HADHA CLSPN DDX24 CCDC86 TOP2A GNL3 AFF4 VDAC1 | 1.19e-13 | 989 | 161 | 27 | 36424410 |
| Pubmed | NOLC1 ELOA ELOA2 NHSL2 NUMA1 MAGI3 NCL BRD3 XPC RPL14 HMGA1 ESF1 HP1BP3 C9orf43 TNRC18 PHF20L1 FAM50A CDK13 RBMX2 AHNAK H1-3 XRN1 SMARCC1 PIP4K2B H1-1 HADHA SPAG17 CEP57 ARHGAP21 TOP2A TBX1 BAHCC1 | 1.37e-13 | 1442 | 161 | 32 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 H1-10 KIF23 SETX NACA DLGAP5 NUMA1 CKAP5 KIF4A NCL XPC RPL14 HMGA1 ATAD2 IFI16 ESF1 LIG3 AHNAK MKI67 XRN1 SF3A3 SMARCC1 PDCD11 H1-1 RAI14 HADHA PARD3 DDX24 CCDC86 TOP2A GNL3 | 1.52e-13 | 1353 | 161 | 31 | 29467282 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | NOLC1 ELOA TCOF1 ZNF280C NCL XPC ESF1 RBMX2 MKI67 NUCKS1 DDX24 TOP2A AFF4 | 2.44e-13 | 148 | 161 | 13 | 32538781 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 H1-10 KIF23 TCOF1 RBBP6 NACA NUMA1 NCL RPL14 HMGA1 IFI16 HP1BP3 CDK13 NOM1 RBMX2 AHNAK NUFIP2 H1-3 RPS19BP1 MKI67 PDCD11 RAI14 HADHA CCDC86 TOP2A GNL3 | 3.28e-13 | 949 | 161 | 26 | 36574265 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | CUL4B ELOA RBBP6 ZNF280C NUMA1 KIF4A NCL MED1 IFI16 ESF1 LIG3 SCML2 MKI67 SUGP1 TOP2A AFF4 | 3.79e-13 | 283 | 161 | 16 | 30585729 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 H1-10 ELOA KIF23 RBBP6 ZC3H13 NACA NUMA1 CKAP5 NCL RPL14 IFI16 ESF1 HP1BP3 FAM83F NOM1 AHNAK STAU2 NUFIP2 H1-3 MKI67 SF3A3 PDCD11 RAI14 HADHA DDX24 TOP2A GNL3 VDAC1 | 8.73e-13 | 1257 | 161 | 29 | 36526897 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 H1-10 ELOA TCOF1 ATAD5 ZC3H13 NUMA1 NCL RPL14 HP1BP3 LIG3 NOM1 NUFIP2 MKI67 SF3A3 SMARCC1 PDCD11 DDX24 TOP2A GNL3 VDAC1 | 9.11e-13 | 605 | 161 | 21 | 28977666 |
| Pubmed | NOLC1 H1-10 HIRIP3 RBBP6 ZC3H13 NCL BRD3 XPC HP1BP3 RBMX2 AHNAK H1-3 SUGP1 SMARCC1 TOP2A | 9.56e-13 | 251 | 161 | 15 | 31076518 | |
| Pubmed | SOX4 NOLC1 H1-10 ZNF609 KIF23 ARID4B ARID4A RBBP6 ATAD5 NACA NUMA1 RPL14 HP1BP3 PHF2 LIG3 FBN2 STAU2 MKI67 XRN1 SUGP1 SMARCC1 PDCD11 RAI14 ELK4 HADHA DDX24 CCDC86 SLX4 GNL3 VDAC1 | 3.58e-12 | 1429 | 161 | 30 | 35140242 | |
| Pubmed | CUL4B NOLC1 ELOA EDF1 KIF23 RBBP6 ATAD5 NUMA1 KIF4A NCL BRD3 HMGA1 MED1 IFI16 ESF1 HP1BP3 LIG3 FAM50A CDK13 AHNAK MKI67 NUCKS1 SMARCC1 TOP2A GNL3 | 9.59e-12 | 1014 | 161 | 25 | 32416067 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | CUL4B TCOF1 NACA NUMA1 CKAP5 KIF4A BRD3 AHNAK TET1 SF3A3 SMARCC1 RAI14 HADHA | 1.39e-11 | 203 | 161 | 13 | 22083510 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 H1-10 AGPAT5 TCOF1 RBBP6 ZC3H13 NACA NUMA1 AASDHPPT NCL RPL14 HP1BP3 PHF2 CCDC71 RBMX2 AHNAK STAU2 H1-3 MKI67 SF3A3 SMARCC1 PDCD11 PIP4K2B NKTR HADHA DDX24 TOP2A GNL3 | 1.58e-11 | 1318 | 161 | 28 | 30463901 |
| Pubmed | NOLC1 H1-10 ZNF609 KIF23 TCOF1 RBBP6 NUMA1 KIF4A NCL RPL14 MED1 ESF1 LIG3 TNRC18 NEMF NUFIP2 H1-3 MKI67 XRN1 SMARCC1 RAI14 HADHA PARD3 DDX24 TOP2A GNL3 AFF4 | 2.49e-11 | 1247 | 161 | 27 | 27684187 | |
| Pubmed | NOLC1 H1-10 TCOF1 RBBP6 ATAD5 NACA NUMA1 TOPBP1 NCL RPL14 HMGA1 ATAD2 HP1BP3 AHNAK MKI67 SF3A3 CCDC86 TOP2A GNL3 VDAC1 | 3.02e-11 | 652 | 161 | 20 | 31180492 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | NOLC1 H1-10 ZNF280C KAT6A NUMA1 NOM1 RBMX2 STAU2 PDCD11 NKTR DDX24 CCDC86 TOP2A GNL3 VDAC1 | 4.70e-11 | 330 | 161 | 15 | 33301849 |
| Pubmed | KIF23 NUMA1 CKAP5 ATAD2 IFI16 ESF1 HP1BP3 NEMF MKI67 XRN1 PDCD11 DDX24 CCDC86 TOP2A GNL3 | 5.12e-11 | 332 | 161 | 15 | 25693804 | |
| Pubmed | 5.17e-11 | 72 | 161 | 9 | 31248990 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H1-10 HIRIP3 ATAD5 NUMA1 KIF4A BRD3 XPC MED1 LIG3 SCML2 AHNAK PDCD11 HADHA DDX24 CCDC86 TOP2A | 5.51e-11 | 394 | 161 | 16 | 27248496 |
| Pubmed | EDF1 SETX RBBP6 ATAD5 C19orf53 NACA TOPBP1 CKAP5 NSD1 KIF4A BRD3 XPC MED1 ATAD2 ESF1 PHF2 SCML2 CDK13 NOM1 RBMX2 STAU2 NUFIP2 XRN1 PDCD11 RAI14 PARD3 CCDC86 GNL3 AFF4 | 5.87e-11 | 1497 | 161 | 29 | 31527615 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 ATAD5 NUMA1 NSD1 BRD3 MED1 ATAD2 HP1BP3 PHF2 LIG3 SCML2 NOM1 H1-3 MKI67 SMARCC1 CCDC86 TOP2A GNL3 | 6.67e-11 | 533 | 161 | 18 | 30554943 |
| Pubmed | H1-10 KIF23 TCOF1 RBBP6 ZC3H13 NUMA1 NCL BRD3 XPC RPL14 ATAD2 IFI16 HP1BP3 NOM1 NUFIP2 MKI67 SF3A3 PDCD11 RAI14 DDX24 CCDC86 TOP2A | 7.08e-11 | 847 | 161 | 22 | 35850772 | |
| Pubmed | CUL4B NOLC1 H1-10 ZNF609 ARID4B TCOF1 RBBP6 ATAD5 KAT6A BRD3 XPC SP110 PHF2 FBN2 XRN1 FGB SMARCC1 PIP4K2B CLSPN PARD3 DDX24 TOP2A GNL3 AFF4 BAHCC1 | 7.31e-11 | 1116 | 161 | 25 | 31753913 | |
| Pubmed | SOX4 H1-10 ELOA ZNF609 KIF23 AGPAT5 ARID4B ARID4A CETN1 C19orf53 C15orf40 RPL14 MED1 ATAD2 ESF1 FAM50A CDK13 BTBD7 XPNPEP3 XRN1 SF3A3 SUGP1 SMARCC1 NKTR CLSPN SLC26A6 VDAC1 | 1.00e-10 | 1327 | 161 | 27 | 32694731 | |
| Pubmed | KIF23 TCOF1 RBBP6 NUMA1 NSD1 KIF4A MED1 ESF1 SCML2 AHNAK TET1 NUFIP2 XRN1 SMARCC1 PDCD11 RAI14 PARD3 TOP2A | 1.08e-10 | 549 | 161 | 18 | 38280479 | |
| Pubmed | NOLC1 H1-10 ELOA NCL RPL14 ESF1 HP1BP3 CDK13 RPS19BP1 MKI67 PDCD11 HADHA DDX24 CCDC86 ARHGAP21 TOP2A GNL3 | 1.23e-10 | 483 | 161 | 17 | 36912080 | |
| Pubmed | NOLC1 H1-10 TCOF1 RBBP6 ZC3H13 NACA NCL RPL14 HMGA1 HP1BP3 RBMX2 NUFIP2 H1-3 SF3A3 PDCD11 DDX24 CCDC86 TOP2A GNL3 VDAC1 | 2.26e-10 | 731 | 161 | 20 | 29298432 | |
| Pubmed | Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. | 2.48e-10 | 9 | 161 | 5 | 2578321 | |
| Pubmed | Germline diversity of the expressed BALB/c VhJ558 gene family. | 2.48e-10 | 9 | 161 | 5 | 11483206 | |
| Pubmed | 2.48e-10 | 9 | 161 | 5 | 6789211 | ||
| Pubmed | NOLC1 H1-10 ZNF609 TCOF1 RBBP6 NCL RPL14 HP1BP3 TNRC18 CDK13 NOM1 STAU2 NUFIP2 H1-3 MKI67 HADHA DDX24 GNL3 VDAC1 | 2.49e-10 | 655 | 161 | 19 | 35819319 | |
| Pubmed | NOLC1 H1-10 TCOF1 RBBP6 NUMA1 KIF4A RPL14 MED1 ESF1 CDK13 MKI67 SF3A3 SUGP1 NUCKS1 SMARCC1 RAI14 HADHA | 2.52e-10 | 506 | 161 | 17 | 30890647 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | NOLC1 TCOF1 RPL14 MED1 ATAD2 ESF1 CDK13 RBMX2 SF3A3 NKTR DDX24 CCDC86 GNL3 | 2.88e-10 | 259 | 161 | 13 | 30404004 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 H1-10 KIF23 TCOF1 ZNF280C NACA NUMA1 CKAP5 NCL RPL14 ATAD2 ESF1 PHF2 LIG3 NEMF MKI67 SF3A3 NUCKS1 SMARCC1 PDCD11 HADHA GALNT5 DDX24 CCDC86 TOP2A GNL3 VDAC1 | 4.79e-10 | 1425 | 161 | 27 | 30948266 |
| Pubmed | 4.94e-10 | 10 | 161 | 5 | 3211160 | ||
| Pubmed | 6.29e-10 | 64 | 161 | 8 | 22865885 | ||
| Pubmed | CUL4B NOLC1 SETX RBBP6 NUMA1 BRD3 HMGA1 LIG3 C9orf43 CDK13 NOM1 AHNAK H1-3 RPS19BP1 SMARCC1 TOP2A | 6.99e-10 | 469 | 161 | 16 | 27634302 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B NOLC1 ZNF609 KIF23 NACA NUMA1 TOPBP1 CKAP5 KIF4A XPC HMGA1 PHF20L1 RBMX2 AHNAK MKI67 SF3A3 FGB SMARCC1 RAI14 HADHA SLX4 TOP2A GNL3 VDAC1 | 8.17e-10 | 1155 | 161 | 24 | 20360068 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | EDF1 ZNF609 ATAD5 CKAP5 XPC HMGA1 MED1 SCML2 FAM50A NOM1 AHNAK STAU2 NUFIP2 MKI67 XRN1 SMARCC1 TMEM131 HADHA DDX24 | 1.31e-09 | 724 | 161 | 19 | 36232890 |
| Pubmed | 1.35e-09 | 103 | 161 | 9 | 32744500 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 H1-10 EDF1 TCOF1 NACA NUMA1 CKAP5 KIF4A NCL RPL14 HMGA1 WARS2 HP1BP3 FAM50A CDK13 AHNAK XPNPEP3 NEMF SF3A3 SMARCC1 HADHA DDX24 CCDC86 TOP2A GNL3 VDAC1 | 1.99e-09 | 1415 | 161 | 26 | 28515276 |
| Pubmed | SOX4 RBBP6 NUMA1 NCL BRD3 HMGA1 HP1BP3 STAU2 DDX24 TOP2A GNL3 | 2.08e-09 | 195 | 161 | 11 | 19454010 | |
| Pubmed | H1-10 EDF1 SETX TCOF1 NACA NUMA1 NCL RPL14 HP1BP3 STAU2 NEMF NUFIP2 SMARCC1 H1-1 HADHA TOP2A GNL3 | 4.74e-09 | 615 | 161 | 17 | 31048545 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TCOF1 NUMA1 KIF4A NCL MED1 SCML2 AHNAK MKI67 SF3A3 SMARCC1 HADHA TOP2A | 5.84e-09 | 271 | 161 | 12 | 32433965 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | H1-10 ELOA ZNF609 AGPAT5 TCOF1 RBBP6 ZNF280C CKAP5 NCL XPC RPL14 IFI16 HP1BP3 OTX1 FBN2 NOM1 AHNAK NUFIP2 MKI67 SMARCC1 H1-1 SLX4 TOP2A | 9.07e-09 | 1203 | 161 | 23 | 29180619 |
| Pubmed | CUL4B ELOA ZNF609 KIF23 NACA DLGAP5 KIF4A SCML2 NUFIP2 XRN1 SF3A3 SUGP1 NUCKS1 PIP4K2B TMEM131 CLSPN SLC26A6 GNL3 | 1.02e-08 | 733 | 161 | 18 | 34672954 | |
| Pubmed | H1-10 ELOA C19orf53 KAT6A RPL14 HMGA1 TERF1 ESF1 HP1BP3 SF3A3 CCDC86 TOP2A GNL3 AFF4 | 1.04e-08 | 417 | 161 | 14 | 36537216 | |
| Pubmed | ZNF609 SETX NACA NCL ANKRD50 ESF1 HP1BP3 LIG3 FREM2 CDK13 NOM1 NEMF H1-3 XRN1 SMARCC1 CLSPN ARHGAP21 | 1.07e-08 | 650 | 161 | 17 | 38777146 | |
| Pubmed | 1.18e-08 | 17 | 161 | 5 | 37072811 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | NOLC1 H1-10 DLGAP5 NUMA1 NCL RPL14 H1-3 SF3A3 FGB SMARCC1 PDCD11 CCDC86 TOP2A GNL3 | 1.53e-08 | 430 | 161 | 14 | 38172120 |
| Pubmed | HIRIP3 TCOF1 NACA KIF4A GBP2 AASDHPPT NCL LIG3 H1-8 NUFIP2 H1-3 MKI67 SF3A3 SMARCC1 GALNT5 DDX24 ARHGAP21 VDAC1 | 1.57e-08 | 754 | 161 | 18 | 35906200 | |
| Pubmed | RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation. | 1.63e-08 | 18 | 161 | 5 | 27558965 | |
| Pubmed | 1.63e-08 | 18 | 161 | 5 | 6788376 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | H1-10 RBBP6 C19orf53 NACA NCL RPL14 CDK13 NOM1 STAU2 NUFIP2 RPS19BP1 SMARCC1 PDCD11 HADHA DDX24 CCDC86 GNL3 | 1.98e-08 | 678 | 161 | 17 | 30209976 |
| Pubmed | 1.99e-08 | 64 | 161 | 7 | 34174788 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | NOLC1 PDE3A KIF23 ZC3H13 NUMA1 NCL RAI14 HADHA PARD3 ARHGAP21 | 2.22e-08 | 190 | 161 | 10 | 15161933 |
| Pubmed | NOLC1 KIF23 SETX HIRIP3 TCOF1 KIF4A NCL ANKRD50 ESF1 HP1BP3 NOM1 AHNAK MKI67 XRN1 RAI14 CLSPN PARD3 ARHGAP21 | 2.47e-08 | 777 | 161 | 18 | 35844135 | |
| Pubmed | NOLC1 H1-10 TCOF1 ARID4A CKAP5 NCL RPL14 HMGA1 PHF2 HADHA GNL3 VDAC1 | 3.31e-08 | 317 | 161 | 12 | 30997501 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | KIF23 TCOF1 NACA DLGAP5 CKAP5 AHNAK NUFIP2 XRN1 SUGP1 NUCKS1 RAI14 | 3.49e-08 | 256 | 161 | 11 | 33397691 |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 3.52e-08 | 41 | 161 | 6 | 20431927 | |
| Pubmed | 4.57e-08 | 72 | 161 | 7 | 12777385 | ||
| Pubmed | EDF1 TCOF1 RBBP6 ZC3H13 NUMA1 NCL MED1 FAM50A AHNAK NUFIP2 MKI67 SF3A3 SMARCC1 | 5.06e-08 | 399 | 161 | 13 | 35987950 | |
| Pubmed | TCOF1 RPL14 ESF1 HP1BP3 PHF2 RPS19BP1 MKI67 SMARCC1 PDCD11 DDX24 TOP2A VDAC1 | 5.67e-08 | 333 | 161 | 12 | 36779763 | |
| Pubmed | 6.13e-08 | 159 | 161 | 9 | 22751105 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 H1-10 TCOF1 NACA NUMA1 CKAP5 NCL RPL14 HMGA1 HP1BP3 LIG3 AHNAK XPNPEP3 MKI67 SF3A3 PDCD11 HADHA CCDC86 TOP2A GNL3 | 6.52e-08 | 1024 | 161 | 20 | 24711643 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | H1-10 NACA CKAP5 NCL RPL14 LIG3 NOM1 RBMX2 NEMF SMARCC1 PDCD11 HADHA DDX24 GNL3 | 6.98e-08 | 486 | 161 | 14 | 30940648 |
| Pubmed | NOLC1 KIF23 TCOF1 NACA NUMA1 CKAP5 NCL RPL14 HP1BP3 AHNAK NUFIP2 MKI67 SF3A3 SMARCC1 | 8.53e-08 | 494 | 161 | 14 | 26831064 | |
| Pubmed | KIF23 RBBP6 AFF3 HMGA1 SNX19 FAM222A STAU2 NEMF H1-1 HADHA CCDC86 TOP2A GNL3 AFF4 | 8.96e-08 | 496 | 161 | 14 | 31343991 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CUL4B NHSL2 ZC3H13 NACA NUMA1 TOPBP1 CKAP5 AASDHPPT NCL RPL14 LIG3 FAM50A H1-3 SF3A3 NUCKS1 SMARCC1 H1-1 VDAC1 | 9.00e-08 | 847 | 161 | 18 | 35235311 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 9.21e-08 | 221 | 161 | 10 | 29991511 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | H1-10 NUMA1 IFI16 HP1BP3 LIG3 STAU2 NUFIP2 MKI67 PDCD11 DDX24 CCDC86 GNL3 | 9.43e-08 | 349 | 161 | 12 | 25665578 |
| Pubmed | 1.02e-07 | 121 | 161 | 8 | 22412018 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | KIF23 NACA NUMA1 TOPBP1 KIF4A NCL RPL14 NUFIP2 MKI67 SMARCC1 CLSPN SLX4 | 1.20e-07 | 357 | 161 | 12 | 37059091 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | ZC3H13 NUMA1 NCL RPL14 PRAG1 HP1BP3 MKI67 PDCD11 RAI14 TMEM131 ARHGAP21 GNL3 | 1.36e-07 | 361 | 161 | 12 | 30344098 |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 1.42e-07 | 11 | 161 | 4 | 26689747 | |
| Pubmed | CUL4B H1-10 KIF23 NUMA1 NCL RPL14 IFI16 HP1BP3 NOM1 AHNAK NEMF RAI14 CCDC86 TOP2A GNL3 | 1.50e-07 | 601 | 161 | 15 | 33658012 | |
| Pubmed | 1.57e-07 | 234 | 161 | 10 | 36243803 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | EDF1 RBBP6 ZC3H13 CKAP5 NCL HMGA1 MED1 RBMX2 NUFIP2 SUGP1 SMARCC1 GOLGA8B PIP4K2B NKTR GOLGA8A TOP2A | 1.89e-07 | 701 | 161 | 16 | 30196744 |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 2.13e-07 | 12 | 161 | 4 | 22650316 | |
| Pubmed | NOLC1 EDF1 ZNF609 SETX C19orf53 CKAP5 KIF4A PTPN22 HMGA1 MED1 IFI16 PHF2 TNRC18 CDK13 MKI67 SUGP1 NUCKS1 SMARCC1 HADHA TOP2A | 2.14e-07 | 1103 | 161 | 20 | 34189442 | |
| Pubmed | ZNF609 KIF23 SETX ATAD5 TOPBP1 NSD1 MED1 IFI16 TERF1 SP110 LIG3 SMARCC1 SLX4 | 2.18e-07 | 453 | 161 | 13 | 29656893 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | CUL4B H1-10 NACA NUMA1 NCL RPL14 HP1BP3 STAU2 NUFIP2 MKI67 SF3A3 H1-1 HADHA DDX24 TOP2A GNL3 | 2.41e-07 | 714 | 161 | 16 | 28302793 |
| Pubmed | 2.89e-07 | 250 | 161 | 10 | 33536335 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | H1-10 ELOA NCL IFI16 LIG3 H1-3 SF3A3 SMARCC1 PDCD11 DDX24 GNL3 | 2.91e-07 | 316 | 161 | 11 | 31665637 |
| Pubmed | CUL4B H1-10 TCOF1 IGHV1-18 ZNF280C NUMA1 NCL RPL14 HMGA1 NUFIP2 MKI67 SF3A3 PDCD11 TOP2A GNL3 | 3.39e-07 | 641 | 161 | 15 | 36057605 | |
| Pubmed | EDF1 ZNF609 C19orf53 NACA XPC HMGA1 SCML2 H1-3 SUGP1 HADHA DDX24 CCDC86 | 3.65e-07 | 396 | 161 | 12 | 26687479 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ZNF609 TCOF1 RBBP6 CKAP5 NCL BRD3 RPL14 HMGA1 HP1BP3 CDK13 SUGP1 HADHA DDX24 TOP2A GNL3 | 5.39e-07 | 665 | 161 | 15 | 30457570 |
| Interaction | SMC5 interactions | CUL4B NOLC1 H1-10 ELOA EDF1 ZNF609 KIF23 SETX ARID4B ARID4A RBBP6 ATAD5 C19orf53 ZC3H13 ZNF280C DLGAP5 NUMA1 TOPBP1 NSD1 KIF4A NCL HMGA1 MED1 ESF1 HP1BP3 PHF2 LIG3 SCML2 AHNAK STAU2 NUFIP2 MKI67 SF3A3 SUGP1 SMARCC1 PDCD11 H1-1 DDX24 CCDC86 SLX4 TOP2A GNL3 AFF4 VDAC1 | 1.96e-22 | 1000 | 150 | 44 | int:SMC5 |
| Interaction | CBX3 interactions | CUL4B ELOA KIF23 TCOF1 RBBP6 ATAD5 ZC3H13 ZNF280C NUMA1 TOPBP1 NSD1 KIF4A BRD3 XPC HMGA1 MED1 ATAD2 IFI16 SP110 ESF1 HP1BP3 LIG3 SCML2 L3MBTL1 CCDC71 FAM50A RPS19BP1 MKI67 SUGP1 NUCKS1 CLSPN SLX4 TOP2A VDAC1 | 1.18e-19 | 646 | 150 | 34 | int:CBX3 |
| Interaction | H2BC21 interactions | CUL4B H1-10 KIF23 ARID4B HIRIP3 ARID4A ATAD5 ZNF280C KAT6A NUMA1 NSD1 KIF4A NCL XPC HMGA1 ATAD2 IFI16 HP1BP3 PHF2 LIG3 SCML2 CCDC71 AHNAK TET1 H1-3 MKI67 EXO1 NUCKS1 SMARCC1 H1-1 CCDC86 TOP2A BAHCC1 | 1.01e-17 | 696 | 150 | 33 | int:H2BC21 |
| Interaction | H2BC8 interactions | ELOA EDF1 KIF23 ARID4B HIRIP3 ARID4A ATAD5 ZNF280C DLGAP5 NUMA1 TOPBP1 NSD1 KIF4A BRD3 XPC HMGA1 ATAD2 ESF1 HP1BP3 PHF2 LIG3 SCML2 FAM50A MKI67 SUGP1 NUCKS1 SMARCC1 CCDC86 TOP2A VDAC1 | 3.00e-17 | 576 | 150 | 30 | int:H2BC8 |
| Interaction | H3-3A interactions | ELOA KIF23 ARID4B HIRIP3 ATAD5 ZNF280C KAT6A NUMA1 TOPBP1 CKAP5 NSD1 KIF4A NCL BRD3 XPC HMGA1 MED1 ATAD2 HP1BP3 PHF2 LIG3 SCML2 CCDC71 PHF20L1 FAM50A H1-3 MKI67 SMARCC1 H1-1 ELK4 TOP2A GNL3 AFF4 | 8.86e-17 | 749 | 150 | 33 | int:H3-3A |
| Interaction | NAA40 interactions | NOLC1 ELOA EDF1 KIF23 TCOF1 RBBP6 ATAD5 ZNF280C NACA DLGAP5 NUMA1 CKAP5 KIF4A AASDHPPT NCL XPC RPL14 HMGA1 MED1 ESF1 HP1BP3 LIG3 SCML2 FAM50A AHNAK STAU2 NUFIP2 MKI67 XRN1 SUGP1 NUCKS1 RAI14 ARHGAP21 TOP2A GNL3 AFF4 VDAC1 | 1.19e-16 | 978 | 150 | 37 | int:NAA40 |
| Interaction | H3C1 interactions | CUL4B H1-10 ELOA EDF1 KIF23 ARID4B ATAD5 ZNF280C KAT6A NACA DLGAP5 NUMA1 NSD1 KIF4A BRD3 XPC HMGA1 ATAD2 HP1BP3 LIG3 TNRC18 FAM50A CDK13 AHNAK H1-3 MKI67 NAV3 NUCKS1 H1-1 ELK4 HADHA DDX24 TOP2A GNL3 AFF4 | 4.22e-16 | 901 | 150 | 35 | int:H3C1 |
| Interaction | H3C3 interactions | ELOA KIF23 SETX ARID4A ATAD5 ZNF280C DLGAP5 NUMA1 TOPBP1 NSD1 KIF4A BRD3 XPC MED1 ATAD2 HP1BP3 PHF2 LIG3 SCML2 FAM50A RBMX2 MKI67 SMARCC1 DDX24 CCDC86 TOP2A AFF4 | 4.51e-16 | 495 | 150 | 27 | int:H3C3 |
| Interaction | TERF2IP interactions | ELOA ZNF609 KIF23 SETX RBBP6 ATAD5 ZNF280C NUMA1 TOPBP1 NSD1 KIF4A MED1 TERF1 HP1BP3 LIG3 FAM50A CDK13 MKI67 SF3A3 SUGP1 NUCKS1 SMARCC1 H1-1 CLSPN DDX24 SLX4 TOP2A AFF4 | 7.70e-16 | 552 | 150 | 28 | int:TERF2IP |
| Interaction | ZNF330 interactions | NOLC1 H1-10 ELOA ARID4B ATAD5 ZNF280C TOPBP1 NSD1 KIF4A NCL BRD3 XPC HMGA1 ESF1 HP1BP3 PHF2 LIG3 OTX1 FAM50A SMARCC1 PDCD11 DDX24 TOP2A GNL3 AFF4 | 3.32e-15 | 446 | 150 | 25 | int:ZNF330 |
| Interaction | NOP56 interactions | NOLC1 H1-10 ELOA KIF23 HIRIP3 TCOF1 ATAD5 NSD1 NCL BRD3 RPL14 IFI16 ESF1 PHF2 L3MBTL1 NOM1 RBMX2 NEMF H1-3 MKI67 PDCD11 DDX24 CCDC86 TOP2A GNL3 AFF4 VDAC1 | 1.42e-14 | 570 | 150 | 27 | int:NOP56 |
| Interaction | NUP43 interactions | H1-10 ZNF609 SETX ARID4B ARID4A RBBP6 ZC3H13 ZNF280C TOPBP1 NSD1 XPC ATAD2 IFI16 HP1BP3 PHF2 LIG3 PHF20L1 RBMX2 MKI67 SMARCC1 PDCD11 H1-1 NKTR DDX24 SLX4 TOP2A GNL3 VDAC1 | 1.75e-14 | 625 | 150 | 28 | int:NUP43 |
| Interaction | DDX23 interactions | NOLC1 ELOA KIF23 TCOF1 RBBP6 ZC3H13 NCL XPC IFI16 TERF1 ESF1 PHF2 LIG3 FAM50A CDK13 RBMX2 SF3A3 SUGP1 PDCD11 PIP4K2B NKTR DDX24 TOP2A GNL3 AFF4 | 1.78e-14 | 480 | 150 | 25 | int:DDX23 |
| Interaction | RPL31 interactions | CUL4B NOLC1 H1-10 ELOA EDF1 KIF23 TCOF1 ATAD5 C19orf53 ZC3H13 KAT6A NACA NSD1 NCL BRD3 RPL14 ESF1 PHF2 LIG3 FAM50A NOM1 STAU2 H1-3 MKI67 PDCD11 DDX24 CCDC86 TOP2A GNL3 | 1.97e-14 | 680 | 150 | 29 | int:RPL31 |
| Interaction | SIRT7 interactions | CUL4B NOLC1 H1-10 KIF23 TCOF1 ZC3H13 NUMA1 CKAP5 NSD1 KIF4A NCL RPL14 ATAD2 ESF1 HP1BP3 AHNAK NUFIP2 H1-3 MKI67 XRN1 SMARCC1 PDCD11 H1-1 ELK4 HADHA DDX24 CCDC86 TOP2A GNL3 VDAC1 | 2.85e-14 | 744 | 150 | 30 | int:SIRT7 |
| Interaction | NIFK interactions | NOLC1 ELOA KIF23 TCOF1 RBBP6 ATAD5 KAT6A NSD1 NCL BRD3 RPL14 IFI16 ESF1 NOM1 RBMX2 STAU2 MKI67 PDCD11 H1-1 DDX24 CCDC86 GNL3 AFF4 | 1.32e-13 | 431 | 150 | 23 | int:NIFK |
| Interaction | HECTD1 interactions | NOLC1 H1-10 ELOA KIF23 ARID4B RBBP6 ATAD5 KAT6A NACA NUMA1 TOPBP1 CKAP5 KIF4A NCL RPL14 MED1 TERF1 ESF1 HP1BP3 LIG3 CDK13 NOM1 STAU2 NEMF NUFIP2 MKI67 XRN1 EXO1 PDCD11 DDX24 CCDC86 TOP2A GNL3 | 2.16e-13 | 984 | 150 | 33 | int:HECTD1 |
| Interaction | MECP2 interactions | NOLC1 ELOA EDF1 SETX TCOF1 MAP6 RBBP6 ZC3H13 NSD1 NCL BRD3 XPC RPL14 HMGA1 MED1 TERF1 ESF1 HP1BP3 PHF2 LIG3 RBMX2 XPNPEP3 STAU2 NEMF NUFIP2 MKI67 SF3A3 SUGP1 NUCKS1 SMARCC1 PDCD11 NKTR HADHA DDX24 CCDC86 AFF4 VDAC1 | 6.14e-13 | 1287 | 150 | 37 | int:MECP2 |
| Interaction | CENPA interactions | H1-10 KIF23 HIRIP3 ATAD5 ZC3H13 KAT6A NSD1 KIF4A BRD3 XPC HMGA1 ATAD2 ESF1 HP1BP3 PHF2 LIG3 SMARCC1 PDCD11 H1-1 DDX24 TOP2A | 7.37e-13 | 377 | 150 | 21 | int:CENPA |
| Interaction | PARP1 interactions | NOLC1 ELOA KIF23 ARID4B ATAD5 CETN1 NUMA1 TOPBP1 NSD1 KIF4A NCL BRD3 XPC RPL14 HMGA1 MED1 ATAD2 IFI16 ESF1 HP1BP3 PHF2 LIG3 C9orf43 FAM50A CDK13 H1-3 MKI67 NUCKS1 SMARCC1 PDCD11 H1-1 HADHA CLSPN SLX4 TOP2A GNL3 AFF4 | 1.20e-12 | 1316 | 150 | 37 | int:PARP1 |
| Interaction | POLR1G interactions | NOLC1 ELOA ARID4B TCOF1 ATAD5 KAT6A NUMA1 TOPBP1 NSD1 NCL BRD3 XPC ESF1 PHF2 LIG3 FAM50A RBMX2 PDCD11 CLSPN DDX24 TOP2A GNL3 AFF4 | 1.82e-12 | 489 | 150 | 23 | int:POLR1G |
| Interaction | CHD4 interactions | NOLC1 H1-10 ELOA KIF23 TCOF1 RBBP6 KAT6A NUMA1 NCL BRD3 RPL14 HMGA1 IFI16 HP1BP3 LIG3 PHF20L1 NOM1 AHNAK NUFIP2 RPS19BP1 MKI67 XRN1 SF3A3 SMARCC1 PDCD11 H1-1 DDX24 SLX4 TOP2A GNL3 VDAC1 | 1.93e-12 | 938 | 150 | 31 | int:CHD4 |
| Interaction | CIT interactions | NOLC1 H1-10 KIF23 SETX TCOF1 RBBP6 ZC3H13 NACA NUMA1 CKAP5 MAGI3 NCL BRD3 RPL14 HMGA1 MED1 IFI16 ESF1 HP1BP3 PHF2 LIG3 AHNAK NUFIP2 H1-3 MKI67 SF3A3 NANOS3 SMARCC1 PDCD11 RAI14 NKTR HADHA PARD3 SPAG17 CCDC86 TOP2A GNL3 VDAC1 | 4.66e-12 | 1450 | 150 | 38 | int:CIT |
| Interaction | NSD2 interactions | TCOF1 ZNF280C NUMA1 NCL BRD3 RPL14 HMGA1 IFI16 HP1BP3 SCML2 CCDC71 RBMX2 MKI67 FGB NUCKS1 H1-1 TOP2A | 3.04e-11 | 278 | 150 | 17 | int:NSD2 |
| Interaction | H2BC5 interactions | NOLC1 TCOF1 NUMA1 CKAP5 NCL XPC HMGA1 IFI16 H1-8 TNRC18 PHF20L1 NEMF H1-3 MKI67 SMARCC1 ELK4 TOP2A VDAC1 | 5.36e-11 | 331 | 150 | 18 | int:H2BC5 |
| Interaction | POU5F1 interactions | CUL4B TCOF1 C19orf53 NACA NUMA1 CKAP5 KIF4A NCL BRD3 XPC HMGA1 LIG3 SCML2 AHNAK TET1 H1-3 SF3A3 SUGP1 SMARCC1 RAI14 HADHA DDX24 TOP2A | 6.54e-11 | 584 | 150 | 23 | int:POU5F1 |
| Interaction | ADARB1 interactions | TCOF1 NUMA1 KIF4A NCL RPL14 MED1 HP1BP3 SCML2 AHNAK STAU2 MKI67 SF3A3 SMARCC1 PDCD11 H1-1 NKTR HADHA DDX24 CCDC86 TOP2A GNL3 | 9.88e-11 | 489 | 150 | 21 | int:ADARB1 |
| Interaction | H1-4 interactions | NOLC1 KIF23 HIRIP3 TCOF1 NSD1 NCL RPL14 HMGA1 IFI16 HP1BP3 TNRC18 L3MBTL1 CDK13 NOM1 RBMX2 STAU2 H1-3 XRN1 PDCD11 GOLGA8B H1-1 SPAG17 DDX24 TBX1 | 1.09e-10 | 656 | 150 | 24 | int:H1-4 |
| Interaction | RPS6 interactions | CUL4B NOLC1 H1-10 ELOA KIF23 KAT6A NCL BRD3 RPL14 ESF1 HP1BP3 PHF2 LIG3 H1-8 NOM1 RBMX2 STAU2 MKI67 XRN1 PDCD11 H1-1 HADHA DDX24 CCDC86 SLX4 TOP2A GNL3 | 2.88e-10 | 874 | 150 | 27 | int:RPS6 |
| Interaction | H2AZ1 interactions | KIF23 ARID4B ZNF280C KAT6A NUMA1 NSD1 BRD3 XPC HMGA1 HP1BP3 PHF2 LIG3 CCDC71 NUCKS1 SMARCC1 H1-1 TOP2A AFF4 | 3.42e-10 | 371 | 150 | 18 | int:H2AZ1 |
| Interaction | H2BC13 interactions | NOLC1 TCOF1 ATAD5 CKAP5 NCL HMGA1 IFI16 TNRC18 PHF20L1 H1-3 MKI67 SMARCC1 ELK4 TOP2A | 5.94e-10 | 210 | 150 | 14 | int:H2BC13 |
| Interaction | IFI16 interactions | H1-10 ELOA KIF23 NUMA1 CKAP5 NCL ATAD2 IFI16 ESF1 HP1BP3 LIG3 NEMF NUFIP2 H1-3 MKI67 XRN1 SF3A3 SMARCC1 PDCD11 RAI14 DDX24 CCDC86 TOP2A GNL3 | 6.03e-10 | 714 | 150 | 24 | int:IFI16 |
| Interaction | CSNK2A2 interactions | CUL4B NOLC1 ELOA KIF23 ARID4B HIRIP3 TCOF1 KAT6A NACA NCL BRD3 XPC HMGA1 IFI16 TERF1 SP110 ANKRD36B MKI67 NUCKS1 PIP4K2B NKTR HADHA DDX24 TOP2A | 6.74e-10 | 718 | 150 | 24 | int:CSNK2A2 |
| Interaction | RPS16 interactions | CUL4B H1-10 EDF1 KIF23 KAT6A CKAP5 NCL RPL14 TERF1 HP1BP3 CDK13 STAU2 NEMF NUFIP2 H1-3 XRN1 PDCD11 H1-1 DDX24 CEP57 CCDC86 SLX4 TOP2A GNL3 | 7.96e-10 | 724 | 150 | 24 | int:RPS16 |
| Interaction | CBX5 interactions | CUL4B ELOA2 ZNF280C KAT6A NUMA1 NCL BRD3 HMGA1 IFI16 SP110 L3MBTL1 CCDC71 MKI67 XRN1 NUCKS1 H1-1 ZNF625 | 1.39e-09 | 356 | 150 | 17 | int:CBX5 |
| Interaction | NLE1 interactions | TCOF1 RBBP6 ZC3H13 ZNF280C TOPBP1 RPL14 IFI16 MKI67 PDCD11 CLSPN DDX24 CCDC86 TOP2A GNL3 | 1.74e-09 | 228 | 150 | 14 | int:NLE1 |
| Interaction | SNRNP40 interactions | CUL4B ZNF609 SETX TCOF1 RBBP6 ATAD5 ZC3H13 ZNF280C KAT6A NUMA1 XPC ATAD2 PHF20L1 MKI67 SF3A3 SUGP1 SMARCC1 PDCD11 NKTR DDX24 TOP2A GNL3 | 2.06e-09 | 637 | 150 | 22 | int:SNRNP40 |
| Interaction | FBL interactions | CUL4B NOLC1 ELOA EDF1 KIF23 TCOF1 NCL ESF1 L3MBTL1 NOM1 RBMX2 STAU2 NUFIP2 RPS19BP1 MKI67 PDCD11 DDX24 CCDC86 SLX4 TOP2A GNL3 VDAC1 | 2.18e-09 | 639 | 150 | 22 | int:FBL |
| Interaction | GNL3 interactions | CUL4B KIF23 KAT6A NCL RPL14 IFI16 TERF1 SP110 ESF1 RBMX2 STAU2 MKI67 PDCD11 H1-1 DDX24 CCDC86 GNL3 | 2.30e-09 | 368 | 150 | 17 | int:GNL3 |
| Interaction | RPL4 interactions | CUL4B NOLC1 H1-10 KIF23 KAT6A NUMA1 NSD1 GBP2 NCL BRD3 RPL14 IFI16 HP1BP3 CDK13 NOM1 NUFIP2 MKI67 XRN1 PDCD11 H1-1 DDX24 SLX4 TOP2A GNL3 | 2.31e-09 | 764 | 150 | 24 | int:RPL4 |
| Interaction | H2AX interactions | KIF23 ARID4B HIRIP3 ARID4A CETN1 NACA NUMA1 NCL BRD3 XPC RPL14 HMGA1 IFI16 LIG3 TNRC18 SCML2 PHF20L1 MKI67 SMARCC1 H1-1 CCDC86 | 3.20e-09 | 593 | 150 | 21 | int:H2AX |
| Interaction | SRPK2 interactions | NOLC1 HIRIP3 TCOF1 RBBP6 ZC3H13 KAT6A PTPN22 NCL BRD3 RPL14 HMGA1 NPM2 HP1BP3 CDK13 NOM1 RBMX2 MKI67 PDCD11 H1-1 NKTR DDX24 CCDC86 TOP2A | 3.49e-09 | 717 | 150 | 23 | int:SRPK2 |
| Interaction | APEX1 interactions | NOLC1 ELOA KIF23 ARID4B TCOF1 ARID4A ATAD5 C19orf53 ZNF280C KAT6A NUMA1 TOPBP1 NSD1 BMERB1 NCL BRD3 RPL14 HMGA1 TERF1 HP1BP3 PHF2 LIG3 SCML2 CCDC66 FAM50A CDK13 AHNAK SMARCC1 PDCD11 GNL3 AFF4 | 3.66e-09 | 1271 | 150 | 31 | int:APEX1 |
| Interaction | RPS3 interactions | CUL4B EDF1 KIF23 KAT6A CKAP5 NCL RPL14 IFI16 HP1BP3 H1-8 FAM50A CDK13 STAU2 H1-3 NUCKS1 PDCD11 H1-1 PARD3 DDX24 CEP57 SLX4 TOP2A GNL3 | 3.87e-09 | 721 | 150 | 23 | int:RPS3 |
| Interaction | NPM1 interactions | CUL4B H1-10 KIF23 KAT6A NUMA1 NSD1 NCL BRD3 XPC RPL14 HMGA1 SP110 ESF1 NPM2 HP1BP3 NOM1 RBMX2 STAU2 NUFIP2 H1-3 MKI67 PDCD11 H1-1 DDX24 CCDC86 SLX4 TOP2A GNL3 TBX1 VDAC1 | 3.97e-09 | 1201 | 150 | 30 | int:NPM1 |
| Interaction | EED interactions | CUL4B NOLC1 H1-10 SETX AGPAT5 ARID4B TCOF1 RBBP6 ZC3H13 ZNF280C NUMA1 CKAP5 NSD1 KIF4A NCL RPL14 HMGA1 ATAD2 HP1BP3 LIG3 CCDC71 NOM1 SF3A3 NUCKS1 SMARCC1 PDCD11 H1-1 RAI14 HADHA DDX24 TOP2A GNL3 VDAC1 | 5.30e-09 | 1445 | 150 | 33 | int:EED |
| Interaction | TNIP1 interactions | NOLC1 H1-10 ELOA KIF23 TCOF1 RBBP6 NACA NUMA1 NCL RPL14 HMGA1 IFI16 HP1BP3 LIG3 CDK13 NOM1 RBMX2 AHNAK DUSP16 NUFIP2 H1-3 RPS19BP1 MKI67 NUCKS1 PDCD11 RAI14 HADHA CCDC86 TOP2A GNL3 | 5.38e-09 | 1217 | 150 | 30 | int:TNIP1 |
| Interaction | GRWD1 interactions | CUL4B H1-10 KIF23 KAT6A NACA CKAP5 NCL RPL14 IFI16 HP1BP3 NOM1 H1-3 PDCD11 HADHA DDX24 CEP57 TOP2A | 5.48e-09 | 390 | 150 | 17 | int:GRWD1 |
| Interaction | H2BC9 interactions | H1-10 HIRIP3 DLGAP5 NUMA1 CKAP5 NSD1 RPL14 HMGA1 ESF1 H1-8 TNRC18 AHNAK H1-3 H1-1 ELK4 SPAG17 TOP2A AFF4 | 6.30e-09 | 446 | 150 | 18 | int:H2BC9 |
| Interaction | H1-0 interactions | H1-10 NUMA1 BRD3 HMGA1 IFI16 HP1BP3 LIG3 H1-3 MKI67 ALPK3 NUCKS1 H1-1 SLX4 VDAC1 | 7.70e-09 | 256 | 150 | 14 | int:H1-0 |
| Interaction | RPA4 interactions | TCOF1 NACA NUMA1 AASDHPPT NCL XPC RPL14 ESF1 LIG3 CDK13 AHNAK STAU2 NUFIP2 MKI67 SF3A3 PARD3 SLX4 TOP2A | 7.75e-09 | 452 | 150 | 18 | int:RPA4 |
| Interaction | CSNK2B interactions | NOLC1 HIRIP3 TCOF1 KAT6A GBP2 BRD3 XPC ATAD2 IFI16 TERF1 SP110 ESF1 PHF2 LIG3 RBMX2 FGB NKTR CLSPN DDX24 TOP2A VDAC1 | 8.04e-09 | 625 | 150 | 21 | int:CSNK2B |
| Interaction | MEN1 interactions | CUL4B NOLC1 H1-10 ZNF609 KIF23 TCOF1 RBBP6 ZC3H13 NUMA1 XPC RPL14 MED1 ATAD2 IFI16 HP1BP3 LIG3 SCML2 PHF20L1 NOM1 NUFIP2 MKI67 SF3A3 PDCD11 DDX24 CCDC86 TOP2A AFF4 | 9.73e-09 | 1029 | 150 | 27 | int:MEN1 |
| Interaction | PRC1 interactions | NOLC1 H1-10 KIF23 RBBP6 NACA NUMA1 KIF4A NCL RPL14 HMGA1 ESF1 HP1BP3 LIG3 KIF3B AHNAK XPNPEP3 H1-3 MKI67 SF3A3 NANOS3 PDCD11 RAI14 HADHA TOP2A GNL3 VDAC1 | 1.32e-08 | 973 | 150 | 26 | int:PRC1 |
| Interaction | RPS24 interactions | CUL4B NOLC1 H1-10 ELOA EDF1 KIF23 ATAD5 KAT6A NCL RPL14 ESF1 HP1BP3 PHF2 NOM1 PDCD11 H1-1 DDX24 TOP2A GNL3 | 1.53e-08 | 529 | 150 | 19 | int:RPS24 |
| Interaction | KIF20A interactions | NOLC1 KIF23 SETX RBBP6 NUMA1 NCL RPL14 HMGA1 IFI16 AHNAK XPNPEP3 NUFIP2 H1-3 MKI67 XRN1 SF3A3 NAV3 NANOS3 NUCKS1 H1-1 RAI14 HADHA PARD3 CCDC86 TOP2A GNL3 VDAC1 | 1.55e-08 | 1052 | 150 | 27 | int:KIF20A |
| Interaction | RSL1D1 interactions | NOLC1 H1-10 KIF23 KAT6A NSD1 NCL IFI16 HP1BP3 H1-8 STAU2 H1-3 MKI67 FGB H1-1 NKTR DDX24 CCDC86 VDAC1 | 1.89e-08 | 479 | 150 | 18 | int:RSL1D1 |
| Interaction | H1-2 interactions | CUL4B H1-10 TCOF1 KAT6A TOPBP1 NSD1 KIF4A NCL HMGA1 IFI16 HP1BP3 H1-8 AHNAK H1-3 XRN1 NUCKS1 PDCD11 H1-1 DDX24 PRG4 TBX1 | 2.41e-08 | 666 | 150 | 21 | int:H1-2 |
| Interaction | CDC14B interactions | ELOA ATAD5 ZNF280C BRD3 HMGA1 ANKRD50 ESF1 PHF2 RPS19BP1 NUCKS1 CCDC86 | 2.83e-08 | 158 | 150 | 11 | int:CDC14B |
| Interaction | BRD3 interactions | NOLC1 RBBP6 ATAD5 NUMA1 NSD1 BRD3 MED1 ATAD2 HP1BP3 PHF2 LIG3 SCML2 H1-3 MKI67 SMARCC1 PIP4K2B CCDC86 TOP2A | 3.03e-08 | 494 | 150 | 18 | int:BRD3 |
| Interaction | DOT1L interactions | H1-10 KIF23 TCOF1 RBBP6 ZC3H13 CKAP5 NCL BRD3 XPC HMGA1 ATAD2 IFI16 HP1BP3 NOM1 MKI67 SF3A3 PDCD11 H1-1 RAI14 DDX24 CCDC86 TOP2A GNL3 | 3.15e-08 | 807 | 150 | 23 | int:DOT1L |
| Interaction | ZC3H18 interactions | NOLC1 H1-10 KIF23 TCOF1 RBBP6 ZC3H13 NACA NUMA1 NCL RPL14 HMGA1 TERF1 HP1BP3 RBMX2 NUFIP2 H1-3 SF3A3 PDCD11 NKTR DDX24 CCDC86 TOP2A GNL3 VDAC1 | 3.29e-08 | 877 | 150 | 24 | int:ZC3H18 |
| Interaction | BRCA1 interactions | CUL4B NOLC1 ELOA KIF23 SETX TCOF1 CETN1 NACA NUMA1 TOPBP1 CKAP5 NCL RPL14 IFI16 TERF1 HP1BP3 AHNAK NUFIP2 MKI67 SF3A3 EXO1 SMARCC1 ELK4 CLSPN DDX24 GOLGA8A ARHGAP21 SLX4 TOP2A | 3.77e-08 | 1249 | 150 | 29 | int:BRCA1 |
| Interaction | TERF2 interactions | TCOF1 ZC3H13 KAT6A NUMA1 CKAP5 NCL BRD3 HMGA1 TERF1 CDK13 MKI67 DDX24 SLX4 TOP2A TBX1 | 3.90e-08 | 340 | 150 | 15 | int:TERF2 |
| Interaction | SSRP1 interactions | NOLC1 ELOA KIF23 SETX HIRIP3 RBBP6 ZC3H13 KAT6A BRD3 XPC RPL14 IFI16 PHF2 LIG3 CCDC71 EXO1 SMARCC1 CLSPN TOP2A GNL3 VDAC1 | 3.90e-08 | 685 | 150 | 21 | int:SSRP1 |
| Interaction | H2AC4 interactions | CUL4B H1-10 HIRIP3 ATAD5 NUMA1 XPC HMGA1 HP1BP3 LIG3 SCML2 H1-3 PDCD11 H1-1 DDX24 CCDC86 SLX4 TOP2A VDAC1 | 4.36e-08 | 506 | 150 | 18 | int:H2AC4 |
| Interaction | CHD3 interactions | NOLC1 H1-10 ELOA KIF23 SETX ARID4B ATAD5 ZC3H13 KAT6A NUMA1 NCL RPL14 HP1BP3 LIG3 PHF20L1 MKI67 SMARCC1 PDCD11 DDX24 TOP2A GNL3 VDAC1 | 4.61e-08 | 757 | 150 | 22 | int:CHD3 |
| Interaction | TOP1 interactions | CUL4B H1-10 KIF23 ARID4B TCOF1 RBBP6 KAT6A CKAP5 NCL BRD3 IFI16 HP1BP3 LIG3 NUFIP2 MKI67 SF3A3 EXO1 SMARCC1 DDX24 TOP2A VDAC1 | 5.12e-08 | 696 | 150 | 21 | int:TOP1 |
| Interaction | RAD18 interactions | NOLC1 H1-10 ELOA HIRIP3 RBBP6 ZC3H13 NCL BRD3 XPC SP110 HP1BP3 RBMX2 H1-3 SUGP1 SMARCC1 HADHA TOP2A | 5.60e-08 | 457 | 150 | 17 | int:RAD18 |
| Interaction | BRD7 interactions | NOLC1 H1-10 NACA NUMA1 CKAP5 NCL BRD3 RPL14 HMGA1 LIG3 NOM1 RBMX2 NEMF MKI67 NUCKS1 SMARCC1 PDCD11 HADHA DDX24 GNL3 | 5.76e-08 | 637 | 150 | 20 | int:BRD7 |
| Interaction | PUM3 interactions | KIF23 KAT6A RPL14 IFI16 ESF1 HP1BP3 H1-8 H1-3 MKI67 PDCD11 H1-1 DDX24 GNL3 | 5.90e-08 | 254 | 150 | 13 | int:PUM3 |
| Interaction | ZNF512 interactions | KAT6A NUMA1 RPL14 HMGA1 IFI16 CCDC71 RBMX2 H1-3 MKI67 NUCKS1 PDCD11 H1-1 DDX24 | 6.47e-08 | 256 | 150 | 13 | int:ZNF512 |
| Interaction | SUZ12 interactions | CUL4B NOLC1 H1-10 SETX ZC3H13 NUMA1 NCL HMGA1 HP1BP3 PHF2 LIG3 NOM1 H1-3 MKI67 SF3A3 NUCKS1 SMARCC1 PDCD11 H1-1 CEP57 | 6.88e-08 | 644 | 150 | 20 | int:SUZ12 |
| Interaction | H2BC4 interactions | NOLC1 H1-10 NUMA1 CKAP5 NCL HP1BP3 TNRC18 H1-3 XRN1 SMARCC1 SPAG17 GNL3 VDAC1 | 7.41e-08 | 259 | 150 | 13 | int:H2BC4 |
| Interaction | MYCN interactions | CUL4B NOLC1 H1-10 ZNF609 TCOF1 RBBP6 C19orf53 ZC3H13 NACA NUMA1 NCL RPL14 HMGA1 ESF1 HP1BP3 LIG3 CDK13 NOM1 RBMX2 STAU2 NUFIP2 RPS19BP1 MKI67 SF3A3 SUGP1 SMARCC1 PDCD11 DDX24 CCDC86 GNL3 | 8.08e-08 | 1373 | 150 | 30 | int:MYCN |
| Interaction | NUMA1 interactions | H1-10 ZNF280C KAT6A NUMA1 BRD3 HMGA1 ATAD2 IFI16 TERF1 HP1BP3 LIG3 H1-3 MKI67 NUCKS1 H1-1 SLX4 TOP2A | 8.12e-08 | 469 | 150 | 17 | int:NUMA1 |
| Interaction | MDC1 interactions | ATAD5 NUMA1 TOPBP1 NSD1 NCL BRD3 HMGA1 IFI16 TERF1 LIG3 MKI67 NUCKS1 SMARCC1 RAI14 SLX4 VDAC1 | 8.39e-08 | 414 | 150 | 16 | int:MDC1 |
| Interaction | RPS14 interactions | CUL4B NOLC1 KIF23 RBBP6 KAT6A NCL RPL14 HP1BP3 H1-8 RBMX2 SF3A3 PDCD11 NKTR DDX24 CEP57 CCDC86 TOP2A GNL3 | 8.51e-08 | 529 | 150 | 18 | int:RPS14 |
| Interaction | LINC00240 interactions | 8.74e-08 | 16 | 150 | 5 | int:LINC00240 | |
| Interaction | USP36 interactions | NOLC1 H1-10 ELOA NCL RPL14 IFI16 ESF1 HP1BP3 CDK13 RPS19BP1 MKI67 PDCD11 HADHA DDX24 CCDC86 ARHGAP21 SLX4 TOP2A GNL3 | 1.09e-07 | 599 | 150 | 19 | int:USP36 |
| Interaction | RPL8 interactions | CUL4B KIF23 HIRIP3 KAT6A NCL RPL14 IFI16 H1-8 RBMX2 STAU2 NUFIP2 XRN1 PDCD11 H1-1 DDX24 CCDC86 SLX4 TOP2A | 1.13e-07 | 539 | 150 | 18 | int:RPL8 |
| Interaction | LYAR interactions | NOLC1 ELOA KIF23 NCL BRD3 IFI16 TERF1 TNRC18 PHF20L1 NOM1 STAU2 MKI67 H1-1 DDX24 AFF4 | 1.31e-07 | 373 | 150 | 15 | int:LYAR |
| Interaction | H2BC12 interactions | NOLC1 H1-10 NUMA1 CKAP5 NCL HMGA1 HP1BP3 TNRC18 AHNAK H1-3 XRN1 ELK4 SPAG17 TOP2A | 1.36e-07 | 322 | 150 | 14 | int:H2BC12 |
| Interaction | BRD2 interactions | NOLC1 H1-10 ATAD5 NUMA1 TOPBP1 BRD3 MED1 HP1BP3 PHF2 LIG3 SMARCC1 PIP4K2B DDX24 SLX4 TOP2A GNL3 | 1.36e-07 | 429 | 150 | 16 | int:BRD2 |
| Interaction | SUPT16H interactions | CUL4B ELOA KIF23 CETN1 ZC3H13 BRD3 XPC MED1 IFI16 LIG3 L3MBTL1 SMARCC1 NKTR SLX4 GNL3 VDAC1 | 2.04e-07 | 442 | 150 | 16 | int:SUPT16H |
| Interaction | SCARNA22 interactions | 2.47e-07 | 118 | 150 | 9 | int:SCARNA22 | |
| Interaction | ZBTB2 interactions | NOLC1 H1-10 ZNF280C KAT6A NUMA1 FAM50A NOM1 RBMX2 STAU2 PDCD11 NKTR DDX24 CCDC86 TOP2A GNL3 VDAC1 | 2.60e-07 | 450 | 150 | 16 | int:ZBTB2 |
| Interaction | SLX4 interactions | ELOA KIF23 NACA AFF3 NUMA1 TOPBP1 KIF4A NCL RPL14 ESF1 NUFIP2 MKI67 SUGP1 SMARCC1 PDCD11 CLSPN SLX4 AFF4 | 2.71e-07 | 572 | 150 | 18 | int:SLX4 |
| Interaction | NOC3L interactions | KIF23 TCOF1 NACA RPL14 IFI16 ESF1 H1-3 MKI67 PDCD11 H1-1 DDX24 GNL3 | 2.99e-07 | 244 | 150 | 12 | int:NOC3L |
| Interaction | RRS1 interactions | NOLC1 KIF23 KAT6A NCL BRD3 RPL14 IFI16 HP1BP3 H1-8 H1-3 MKI67 PDCD11 H1-1 GNL3 | 3.14e-07 | 345 | 150 | 14 | int:RRS1 |
| Interaction | PRKRA interactions | TCOF1 KAT6A NCL RPL14 IFI16 HP1BP3 NOM1 RBMX2 STAU2 XRN1 PDCD11 H1-1 DDX24 CCDC86 GNL3 | 3.20e-07 | 400 | 150 | 15 | int:PRKRA |
| Interaction | POLR1E interactions | NOLC1 ELOA TCOF1 ATAD5 NSD1 NCL BRD3 XPC IFI16 ESF1 PHF2 NOM1 TET1 PDCD11 | 3.73e-07 | 350 | 150 | 14 | int:POLR1E |
| Interaction | H1-5 interactions | H1-10 KIF23 NSD1 NCL RPL14 HMGA1 HP1BP3 ANKRD36B C9orf43 L3MBTL1 CDK13 RBMX2 H1-3 H1-1 DDX24 AFF4 | 3.80e-07 | 463 | 150 | 16 | int:H1-5 |
| Interaction | BANF1 interactions | SOX4 KIF23 NUMA1 BRD3 XPC HMGA1 CDK13 NUCKS1 H1-1 TOP2A VDAC1 | 3.81e-07 | 204 | 150 | 11 | int:BANF1 |
| Interaction | XRCC6 interactions | CUL4B ELOA KIF23 RBBP6 ZNF280C NUMA1 NSD1 KIF4A NCL XPC HMGA1 MED1 IFI16 ESF1 PHF2 LIG3 TNRC18 SCML2 MKI67 SUGP1 TOP2A AFF4 VDAC1 | 3.83e-07 | 928 | 150 | 23 | int:XRCC6 |
| Interaction | RPL11 interactions | CUL4B NOLC1 H1-10 KIF23 TCOF1 KAT6A NCL RPL14 HP1BP3 NOM1 RBMX2 NEMF NUFIP2 DDX24 CEP57 CCDC86 SLX4 TOP2A GNL3 | 3.98e-07 | 652 | 150 | 19 | int:RPL11 |
| Interaction | NR2C2 interactions | CUL4B NOLC1 H1-10 AGPAT5 TCOF1 RBBP6 ZC3H13 NACA NUMA1 AASDHPPT NCL RPL14 HP1BP3 PHF2 CCDC71 RBMX2 AHNAK STAU2 H1-3 MKI67 SF3A3 SMARCC1 PDCD11 PIP4K2B NKTR HADHA DDX24 TOP2A GNL3 | 4.42e-07 | 1403 | 150 | 29 | int:NR2C2 |
| Interaction | RNF2 interactions | NOLC1 H1-10 NUMA1 NCL RPL14 HMGA1 TERF1 ESF1 NPM2 HP1BP3 SCML2 CDK13 NOM1 H1-3 RPS19BP1 MKI67 SF3A3 SMARCC1 PDCD11 DDX24 TOP2A GNL3 | 4.67e-07 | 866 | 150 | 22 | int:RNF2 |
| Interaction | SNIP1 interactions | NOLC1 TCOF1 BRD3 RPL14 ANKRD50 ATAD2 ESF1 CDK13 RBMX2 NUFIP2 SF3A3 NKTR DDX24 CCDC86 GNL3 | 5.42e-07 | 417 | 150 | 15 | int:SNIP1 |
| Interaction | PES1 interactions | NOLC1 ELOA KIF23 NCL IFI16 ESF1 TNRC18 MKI67 DDX24 SLX4 GNL3 AFF4 | 5.42e-07 | 258 | 150 | 12 | int:PES1 |
| Cytoband | 14q32.33 | IGHV1-69-2 IGHV1-58 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 IGHV7-4-1 | 1.30e-07 | 228 | 161 | 9 | 14q32.33 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | IGHV1-69-2 IGHV1-58 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2 BTBD7 IGHV7-4-1 DDX24 | 3.45e-05 | 566 | 161 | 10 | chr14q32 |
| Cytoband | 1p12 | 9.20e-05 | 25 | 161 | 3 | 1p12 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV1-69-2 IGHV1-58 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 IGHV7-4-1 | 7.96e-07 | 187 | 98 | 9 | 349 |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 8.22e-05 | 16 | 98 | 3 | 66 | |
| GeneFamily | PHD finger proteins | 1.29e-04 | 90 | 98 | 5 | 88 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.73e-04 | 4 | 98 | 2 | 1145 | |
| GeneFamily | Variable charge X/Y family | 4.30e-04 | 6 | 98 | 2 | 368 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.02e-03 | 9 | 98 | 2 | 1280 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.02e-03 | 9 | 98 | 2 | 1263 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.98e-03 | 46 | 98 | 3 | 622 | |
| GeneFamily | AT-rich interaction domain containing | 2.92e-03 | 15 | 98 | 2 | 418 | |
| GeneFamily | Histones | 3.66e-03 | 116 | 98 | 4 | 864 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 HP1BP3 H1-3 MKI67 NUCKS1 CLSPN TOP2A | 1.49e-10 | 155 | 155 | 12 | M39041 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 H1-10 KIF23 HIRIP3 TCOF1 ATAD5 DLGAP5 CKAP5 KIF4A NCL ATAD2 TERF1 FBN2 RBMX2 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.67e-09 | 578 | 155 | 19 | M2368 |
| Coexpression | HALLMARK_G2M_CHECKPOINT | NOLC1 KIF23 ARID4A NUMA1 KIF4A NCL HMGA1 LIG3 MKI67 EXO1 SMARCC1 TOP2A | 2.80e-09 | 200 | 155 | 12 | M5901 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 H1-10 KIF23 HIRIP3 TCOF1 ATAD5 DLGAP5 CKAP5 KIF4A NCL ATAD2 TERF1 FBN2 RBMX2 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 2.83e-09 | 597 | 155 | 19 | MM1309 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 | 6.26e-09 | 25 | 155 | 6 | MM870 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | KIF23 ATAD5 NACA DLGAP5 KIF4A NCL RPL14 HMGA1 ATAD2 IFI16 TERF1 HP1BP3 PHF20L1 H1-3 MKI67 NUCKS1 SMARCC1 H1-1 HADHA CLSPN TOP2A VDAC1 | 1.51e-08 | 891 | 155 | 22 | M41654 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NOLC1 KIF23 AGPAT5 DLGAP5 CKAP5 KIF4A NCL RPL14 HMGA1 WARS2 ESF1 LIG3 MKI67 SMARCC1 PDCD11 CEP57 TOP2A GNL3 | 2.55e-08 | 612 | 155 | 18 | M4772 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 6.41e-08 | 90 | 155 | 8 | M39250 | |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 KIF23 AGPAT5 HIRIP3 TCOF1 RBBP6 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 NUFIP2 H1-3 MKI67 EXO1 NUCKS1 SMARCC1 CLSPN CEP57 TOP2A GNL3 | 6.63e-08 | 969 | 155 | 22 | M149 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | KIF23 ATAD5 DLGAP5 KIF4A HMGA1 ATAD2 CNTN6 FREM2 TET1 MKI67 RAI14 CLSPN TOP2A | 6.82e-08 | 322 | 155 | 13 | M39060 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 5.77e-07 | 163 | 155 | 9 | M8235 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | H1-10 KIF23 AGPAT5 HIRIP3 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 STAU2 MKI67 EXO1 NUCKS1 SMARCC1 CLSPN TOP2A | 6.27e-07 | 680 | 155 | 17 | MM456 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | CUL4B RBBP6 AFF3 NUMA1 MED1 HP1BP3 CCDC66 PHF20L1 NUFIP2 GOLGA8B NKTR DDX24 GOLGA8A AFF4 | 9.38e-07 | 474 | 155 | 14 | M40991 |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A HP1BP3 MKI67 NUCKS1 TOP2A | 1.35e-06 | 233 | 155 | 10 | M39036 |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 1.38e-06 | 181 | 155 | 9 | M2969 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B KIF23 SETX ARID4B DLGAP5 NCL ATAD2 IFI16 ESF1 PHF20L1 BTBD7 NEMF MKI67 RAI14 NKTR CEP57 | 1.88e-06 | 656 | 155 | 16 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KIF23 SETX SASH1 ARID4A KAT6A DLGAP5 TOPBP1 CKAP5 BMERB1 SOCS6 MED1 TERF1 CDK13 STAU2 NAV3 TMEM131 PARD3 TOP2A | 3.36e-06 | 856 | 155 | 18 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 SCML2 MKI67 EXO1 CLSPN TOP2A | 5.71e-06 | 478 | 155 | 13 | M45785 |
| Coexpression | SHEPARD_BMYB_TARGETS | 6.03e-06 | 76 | 155 | 6 | M15973 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 6.25e-06 | 164 | 155 | 8 | M13108 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 8.13e-06 | 170 | 155 | 8 | M5657 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 8.74e-06 | 81 | 155 | 6 | M45667 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 CKAP5 ATAD2 MKI67 CLSPN TOP2A | 9.42e-06 | 290 | 155 | 10 | M45736 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 | 9.54e-06 | 23 | 155 | 4 | M12322 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 1.05e-05 | 232 | 155 | 9 | M45800 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 1.09e-05 | 127 | 155 | 7 | M40952 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.26e-05 | 300 | 155 | 10 | M45675 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | SOX4 NOLC1 SETX AGPAT5 SASH1 NACA BMERB1 HP1BP3 XRN1 SF3A3 PARD3 TOP2A | 1.32e-05 | 441 | 155 | 12 | M172 |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.41e-05 | 88 | 155 | 6 | M19287 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | HIRIP3 ATAD2 TERF1 HP1BP3 MKI67 NUCKS1 CLSPN TOP2A VDAC1 BAHCC1 | 1.42e-05 | 304 | 155 | 10 | M39208 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.63e-05 | 187 | 155 | 8 | M2984 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | KIF23 DLGAP5 KIF4A ATAD2 PHF2 FAM50A EXO1 RAI14 TOP2A SLC26A6 VDAC1 | 1.65e-05 | 378 | 155 | 11 | M17788 |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.94e-05 | 93 | 155 | 6 | MM1137 | |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 2.05e-05 | 140 | 155 | 7 | M15664 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_DN | 2.08e-05 | 253 | 155 | 9 | M16010 | |
| Coexpression | WELCSH_BRCA1_TARGETS_DN | 2.15e-05 | 141 | 155 | 7 | M2428 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 2.25e-05 | 142 | 155 | 7 | M39078 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NOLC1 KIF23 DLGAP5 TOPBP1 KIF4A XPC C9orf43 RBMX2 H1-3 EXO1 NUCKS1 H1-1 CLSPN CEP57 TOP2A | 2.34e-05 | 714 | 155 | 15 | M1744 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.38e-05 | 323 | 155 | 10 | M2156 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.54e-05 | 199 | 155 | 8 | M5893 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 2.64e-05 | 200 | 155 | 8 | M8069 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.64e-05 | 200 | 155 | 8 | M304 | |
| Coexpression | GSE3982_CTRL_VS_LPS_48H_DC_UP | 2.64e-05 | 200 | 155 | 8 | M5375 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 2.83e-05 | 202 | 155 | 8 | M11840 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KIF23 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 EXO1 SMARCC1 CLSPN TOP2A | 2.90e-05 | 402 | 155 | 11 | MM454 |
| Coexpression | BURTON_ADIPOGENESIS_3 | 3.10e-05 | 101 | 155 | 6 | M1577 | |
| Coexpression | ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN | 3.27e-05 | 31 | 155 | 4 | M16104 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 3.64e-05 | 153 | 155 | 7 | M5588 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | ZC3H13 KAT6A DLGAP5 NUMA1 VCX3B ANKRD50 IFI16 SP110 TNRC18 OTX1 PNPLA1 MKI67 PIP4K2B TOP2A BAHCC1 | 3.86e-05 | 746 | 155 | 15 | M40863 |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 3.95e-05 | 155 | 155 | 7 | MM1259 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL | TCOF1 DLGAP5 KIF4A ATAD2 WARS2 LIG3 FAM13A H1-3 MKI67 H1-1 CLSPN CCDC86 TOP2A GNL3 | 4.68e-05 | 670 | 155 | 14 | M45751 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KIF23 HIRIP3 DLGAP5 TOPBP1 CKAP5 PTPN22 LIG3 STAU2 MKI67 CEP57 TOP2A | 4.90e-05 | 426 | 155 | 11 | M9516 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | KIF23 DLGAP5 KIF4A HMGA1 ATAD2 CNTN6 FREM2 MKI67 CLSPN TOP2A | 5.16e-05 | 354 | 155 | 10 | M39061 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 5.65e-05 | 164 | 155 | 7 | M19957 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 5.87e-05 | 165 | 155 | 7 | M8121 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNPROG | 6.87e-05 | 229 | 155 | 8 | M39062 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ZNF609 SETX ARID4B ARID4A RBBP6 KAT6A NUMA1 NSD1 GBP2 PTPN22 RPL14 MED1 IFI16 SP110 PHF20L1 CDK13 AHNAK NEMF NUFIP2 XRN1 ELK4 DDX24 | 6.97e-05 | 1492 | 155 | 22 | M40023 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KIF23 ATAD5 ZNF280C DLGAP5 CKAP5 KIF4A AASDHPPT ATAD2 ESF1 PHF20L1 CDK13 NOM1 XPNPEP3 STAU2 MKI67 EXO1 NUCKS1 SMARCC1 CCDC86 TOP2A | 7.80e-05 | 1290 | 155 | 20 | M80 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 7.81e-05 | 300 | 155 | 9 | M39059 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | KIF23 AGPAT5 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 7.98e-05 | 450 | 155 | 11 | M45747 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 9.31e-05 | 307 | 155 | 9 | M39058 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | NOLC1 KIF23 AGPAT5 DLGAP5 KIF4A HMGA1 ATAD2 ZNF248 MKI67 EXO1 TOP2A | 9.33e-05 | 458 | 155 | 11 | M8520 |
| Coexpression | CARD_MIR302A_TARGETS | 9.50e-05 | 77 | 155 | 5 | M2208 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 AGPAT5 TCOF1 ATAD5 TOPBP1 ATAD2 ESF1 PHF20L1 RBMX2 NAV3 EXO1 NUCKS1 PDCD11 CLSPN CCDC86 GNL3 | 9.55e-05 | 904 | 155 | 16 | M2325 |
| Coexpression | GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP | 1.05e-04 | 181 | 155 | 7 | M6814 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 1.07e-04 | 79 | 155 | 5 | M40003 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 AGPAT5 TCOF1 ATAD5 TOPBP1 ATAD2 ESF1 PHF20L1 RBMX2 NAV3 EXO1 NUCKS1 PDCD11 CLSPN CCDC86 GNL3 | 1.20e-04 | 922 | 155 | 16 | MM1068 |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 1.20e-04 | 185 | 155 | 7 | M2965 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 1.21e-04 | 81 | 155 | 5 | M1395 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.26e-04 | 250 | 155 | 8 | M11318 | |
| Coexpression | BENPORATH_CYCLING_GENES | KIF23 DLGAP5 TOPBP1 CKAP5 ATAD2 HP1BP3 MKI67 EXO1 NUCKS1 NKTR CLSPN GOLGA8A TOP2A | 1.32e-04 | 648 | 155 | 13 | M8156 |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | 1.38e-04 | 132 | 155 | 6 | MM996 | |
| Coexpression | GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP | 1.42e-04 | 190 | 155 | 7 | M4903 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.42e-04 | 190 | 155 | 7 | M761 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | KIF23 HIRIP3 TCOF1 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 ANKRD36B FAM13A MKI67 EXO1 H1-1 CLSPN TOP2A | 1.48e-04 | 939 | 155 | 16 | M45768 |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN | 1.49e-04 | 134 | 155 | 6 | M1896 | |
| Coexpression | PRC2_EED_DN.V1_DN | 1.56e-04 | 193 | 155 | 7 | M2734 | |
| Coexpression | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP | 1.58e-04 | 46 | 155 | 4 | M7603 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NOLC1 KIF23 HIRIP3 TCOF1 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A BRD3 ATAD2 ANKRD36B RBMX2 MKI67 EXO1 CLSPN CCDC86 TOP2A GNL3 BAHCC1 | 1.63e-04 | 1363 | 155 | 20 | M45782 |
| Coexpression | AFFAR_YY1_TARGETS_DN | 1.65e-04 | 260 | 155 | 8 | M1471 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 1.67e-04 | 195 | 155 | 7 | M4201 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | SOX4 NOLC1 TCOF1 RBBP6 TMIGD3 NCL IFI16 ESF1 BTBD7 TET1 PDCD11 DDX24 CCDC86 GNL3 VDAC1 BAHCC1 | 1.68e-04 | 950 | 155 | 16 | M19907 |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 1.70e-04 | 87 | 155 | 5 | MM1136 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP | 1.72e-04 | 196 | 155 | 7 | M5256 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN | 1.77e-04 | 197 | 155 | 7 | M9247 | |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | 1.79e-04 | 335 | 155 | 9 | M7079 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 1.89e-04 | 199 | 155 | 7 | M9422 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 1.89e-04 | 199 | 155 | 7 | M8029 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP | 1.89e-04 | 199 | 155 | 7 | M7486 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.95e-04 | 200 | 155 | 7 | M3580 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 1.95e-04 | 200 | 155 | 7 | M7143 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.95e-04 | 200 | 155 | 7 | M5041 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN | 1.95e-04 | 200 | 155 | 7 | M5303 | |
| Coexpression | HALLMARK_E2F_TARGETS | 1.95e-04 | 200 | 155 | 7 | M5925 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP | 1.95e-04 | 200 | 155 | 7 | M6551 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP | 1.95e-04 | 200 | 155 | 7 | M6553 | |
| Coexpression | GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP | 1.95e-04 | 200 | 155 | 7 | M3041 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL | 2.03e-04 | 49 | 155 | 4 | M45737 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 2.13e-04 | 143 | 155 | 6 | MM788 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 2.13e-04 | 143 | 155 | 6 | M16927 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL4B NOLC1 SETX ARID4B HIRIP3 TCOF1 ARID4A RBBP6 ATAD5 ZC3H13 CKAP5 NSD1 BMERB1 KIF4A NCL ATAD2 ESF1 CCDC66 L3MBTL1 FAM83F RBMX2 TET1 NEMF MKI67 EXO1 SMARCC1 H1-1 CLSPN CEP57 CCDC86 ARHGAP21 TOP2A GNL3 | 7.05e-11 | 1257 | 153 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL4B NOLC1 SETX ARID4B HIRIP3 TCOF1 ARID4A MAP6 RBBP6 ATAD5 ZC3H13 CKAP5 NSD1 BMERB1 KIF4A NCL ATAD2 ESF1 CCDC66 L3MBTL1 FAM83F RBMX2 TET1 NEMF MKI67 EXO1 SMARCC1 H1-1 CLSPN CEP57 CCDC86 ARHGAP21 TOP2A GNL3 | 7.99e-10 | 1459 | 153 | 34 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ARID4B HIRIP3 ARID4A RBBP6 ATAD5 CKAP5 NCL ESF1 CCDC66 NEMF MKI67 EXO1 CLSPN ARHGAP21 | 6.02e-08 | 311 | 153 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 CKAP5 KIF4A MAGI3 ATAD2 TERF1 MKI67 EXO1 NUCKS1 H1-1 CLSPN TOP2A | 2.01e-07 | 398 | 153 | 15 | GSM399397_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF23 SETX ARID4A ATAD5 CKAP5 NCL ESF1 PHF20L1 TET1 NEMF EXO1 SMARCC1 TMEM131 CLSPN PARD3 CEP57 | 2.97e-07 | 469 | 153 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ELOA HIRIP3 ARID4A RBBP6 ATAD5 NUMA1 CKAP5 NCL ESF1 ZNF248 OTX1 CCDC66 BTBD7 NEMF MKI67 EXO1 NKTR CLSPN ARHGAP21 SLX4 AFF4 | 5.77e-07 | 831 | 153 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 KIF4A XPC TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 1.22e-06 | 399 | 153 | 14 | GSM538345_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | KIF23 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A PTPN22 ATAD2 AHNAK MKI67 EXO1 H1-1 CLSPN TOP2A | 1.68e-06 | 410 | 153 | 14 | GSM538387_500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | SOX4 KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 2.05e-06 | 417 | 153 | 14 | GSM399403_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | SOX4 KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 VDAC1 | 2.11e-06 | 418 | 153 | 14 | GSM538350_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 KIF4A ATAD2 TET1 MKI67 EXO1 SMARCC1 H1-1 CLSPN TOP2A | 2.36e-06 | 422 | 153 | 14 | GSM476658_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | H1-10 KIF23 HIRIP3 RBBP6 ATAD5 KIF4A SOCS6 FREM2 FBN2 RBMX2 CLSPN TOP2A | 3.25e-06 | 316 | 153 | 12 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 KIF4A XPC TET1 MKI67 EXO1 H1-1 CLSPN TOP2A | 4.94e-06 | 388 | 153 | 13 | GSM538352_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | NOLC1 KIF23 ATAD5 DLGAP5 KIF4A ATAD2 TET1 MKI67 EXO1 SMARCC1 H1-1 CLSPN TOP2A | 6.49e-06 | 398 | 153 | 13 | GSM538338_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF23 SETX ATAD5 CKAP5 MAGI3 NCL ATAD2 ESF1 OTX1 PHF20L1 NEMF EXO1 SMARCC1 CLSPN CEP57 | 7.34e-06 | 532 | 153 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | SOX4 KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A | 8.70e-06 | 409 | 153 | 13 | GSM399452_500 |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | SOX4 AGPAT5 HIRIP3 ATAD5 AFF3 KIF4A XPC TET1 MKI67 EXO1 H1-1 TOP2A GNL3 | 1.21e-05 | 422 | 153 | 13 | GSM791124_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | SOX4 KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 1.21e-05 | 422 | 153 | 13 | GSM538357_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | SOX4 H1-10 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 RAI14 CLSPN TOP2A | 1.24e-05 | 423 | 153 | 13 | GSM791126_500 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | H1-10 KIF23 ATAD5 DLGAP5 KIF4A STAU2 MKI67 EXO1 H1-1 TMEM131 CLSPN TOP2A | 2.08e-05 | 380 | 153 | 12 | GSM538207_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CUL4B SOX4 NOLC1 SETX ARID4B ATAD5 CKAP5 NSD1 NCL ATAD2 SP110 ESF1 CCDC66 XPNPEP3 NEMF MKI67 EXO1 SMARCC1 CLSPN CEP57 CCDC86 TOP2A GNL3 | 2.83e-05 | 1241 | 153 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 ARID4B HIRIP3 TCOF1 ARID4A RBBP6 ATAD5 CKAP5 NCL TERF1 ESF1 FREM2 OTX1 CCDC66 NEMF MKI67 EXO1 CLSPN ARHGAP21 GNL3 | 2.96e-05 | 989 | 153 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.10e-05 | 123 | 153 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 3.19e-05 | 397 | 153 | 12 | GSM791143_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | CUL4B NOLC1 TCOF1 ATAD5 ZC3H13 CKAP5 NCL HMGA1 ATAD2 PRAG1 ESF1 FREM2 FAM222A RBMX2 NEMF EXO1 SMARCC1 PDCD11 CEP57 CCDC86 TOP2A GNL3 | 3.21e-05 | 1164 | 153 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 3.47e-05 | 85 | 153 | 6 | GSM791143_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 SMARCC1 H1-1 CLSPN TOP2A | 4.72e-05 | 349 | 153 | 11 | GSM476675_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 5.38e-05 | 419 | 153 | 12 | GSM538348_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 TOPBP1 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A | 5.50e-05 | 420 | 153 | 12 | GSM791141_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 CLSPN TOP2A GNL3 | 5.76e-05 | 422 | 153 | 12 | GSM538355_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 KIF4A TET1 MKI67 SMARCC1 H1-1 TOP2A AFF4 | 5.89e-05 | 423 | 153 | 12 | GSM476655_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ARID4B ARID4A ATAD5 CKAP5 NCL ESF1 CCDC66 TET1 STAU2 MKI67 TMEM131 CLSPN | 7.19e-05 | 432 | 153 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | SOX4 KIF23 DLGAP5 KIF4A MAGI3 ANKRD50 PHF2 TET1 MKI67 H1-1 TOP2A | 7.41e-05 | 367 | 153 | 11 | GSM399391_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 EXO1 H1-1 CLSPN TOP2A | 8.56e-05 | 373 | 153 | 11 | GSM605781_500 |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A VDAC1 | 9.18e-05 | 376 | 153 | 11 | GSM791154_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | CUL4B NOLC1 TCOF1 MAP6 ATAD5 ZC3H13 CKAP5 NCL HMGA1 ATAD2 PRAG1 ESF1 FREM2 FAM222A RBMX2 NEMF EXO1 SMARCC1 PDCD11 CEP57 CCDC86 TOP2A GNL3 | 9.90e-05 | 1347 | 153 | 23 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | SOX4 NOLC1 EDF1 KIF23 ARID4B TCOF1 NHSL2 NCL BRD3 ESF1 SF3A3 SMARCC1 RAI14 | 1.33e-04 | 533 | 153 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | SOX4 KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A | 1.58e-04 | 400 | 153 | 11 | GSM538358_500 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | SOX4 KIF23 ATAD5 AFF3 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A | 1.61e-04 | 401 | 153 | 11 | GSM399450_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.61e-04 | 71 | 153 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | SOX4 KIF23 AGPAT5 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A | 1.65e-04 | 402 | 153 | 11 | GSM791105_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | KIF23 ATAD5 DLGAP5 KIF4A PTPN22 ATAD2 AHNAK MKI67 H1-1 CLSPN TOP2A | 1.65e-04 | 402 | 153 | 11 | GSM605898_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | 1.76e-04 | 338 | 153 | 10 | GSM538347_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 1.76e-04 | 405 | 153 | 11 | GSM538343_500 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 ALPK3 EXO1 H1-1 TOP2A | 1.96e-04 | 410 | 153 | 11 | GSM791122_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A TET1 MKI67 SMARCC1 H1-1 CLSPN TOP2A | 2.04e-04 | 412 | 153 | 11 | GSM605793_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A VDAC1 | 2.08e-04 | 413 | 153 | 11 | GSM791149_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | SOX4 KIF23 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A AFF4 | 2.13e-04 | 414 | 153 | 11 | GSM476660_500 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | HIRIP3 ATAD5 ZNF280C DLGAP5 KIF4A HMGA1 FREM2 FBN2 EXO1 TOP2A | 2.22e-04 | 348 | 153 | 10 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A PRAG1 MKI67 EXO1 H1-1 CLSPN TOP2A | 2.36e-04 | 419 | 153 | 11 | GSM476664_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 EDF1 TCOF1 ATAD5 NCL HMGA1 PRAG1 ESF1 FREM2 OTX1 CCDC86 GNL3 | 2.60e-04 | 496 | 153 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.69e-04 | 291 | 153 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 H1-10 EDF1 TCOF1 ATAD5 NCL RPL14 HMGA1 PRAG1 ESF1 FREM2 OTX1 CCDC71 RBMX2 EXO1 CCDC86 GNL3 BAHCC1 | 2.88e-04 | 991 | 153 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B KIF23 SETX KIF4A MAGI3 ATAD2 TERF1 ESF1 SCML2 FAM50A RBMX2 TET1 SUGP1 EXO1 H1-1 CLSPN | 2.91e-04 | 820 | 153 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CUL4B SOX4 NOLC1 SETX ARID4B ATAD5 CKAP5 NSD1 NCL ATAD2 SP110 ESF1 CCDC66 XPNPEP3 NEMF MKI67 EXO1 SMARCC1 CLSPN CEP57 CCDC86 TOP2A GNL3 | 3.46e-04 | 1468 | 153 | 23 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 3.55e-04 | 84 | 153 | 5 | GSM538345_100 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 3.75e-04 | 85 | 153 | 5 | GSM399450_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 3.75e-04 | 85 | 153 | 5 | GSM476664_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 4.18e-04 | 87 | 153 | 5 | GSM476658_100 | |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | 4.74e-04 | 383 | 153 | 10 | GSM399448_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 4.89e-04 | 90 | 153 | 5 | GSM399397_100 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 4.89e-04 | 90 | 153 | 5 | GSM399403_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.94e-04 | 192 | 153 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 6.01e-04 | 395 | 153 | 10 | GSM538340_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 6.01e-04 | 395 | 153 | 10 | GSM538351_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-2 | 6.39e-04 | 328 | 153 | 9 | GSM605776_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B ARID4A ATAD5 KAT6A DLGAP5 CKAP5 NCL ESF1 CCDC66 TET1 MKI67 TMEM131 CLSPN | 6.47e-04 | 629 | 153 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CUL4B SETX ARID4B HIRIP3 TCOF1 ARID4A ATAD5 CKAP5 NSD1 NCL ATAD2 SP110 ESF1 CCDC66 TET1 STAU2 MKI67 SMARCC1 TMEM131 CLSPN | 6.83e-04 | 1252 | 153 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | CUL4B SOX4 NHSL2 ZC3H13 ESF1 TNRC18 SCML2 PHF20L1 XPNPEP3 TET1 EXO1 SMARCC1 NKTR CEP57 TOP2A | 7.38e-04 | 806 | 153 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 8.08e-04 | 339 | 153 | 9 | GSM399382_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ARID4B ARID4A ATAD5 ZC3H13 KAT6A TOPBP1 KIF4A NCL ESF1 MKI67 TMEM131 TOP2A | 8.13e-04 | 564 | 153 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SOX4 NHSL2 ZC3H13 TNRC18 SCML2 TET1 SMARCC1 NKTR GALNT5 CEP57 | 8.46e-04 | 413 | 153 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CUL4B ZNF609 ARID4B HIRIP3 ARID4A MAP6 ATAD5 ZC3H13 SMCO1 CKAP5 NSD1 BMERB1 ESF1 CCDC66 L3MBTL1 RBMX2 MKI67 EXO1 CLSPN ARHGAP21 TOP2A | 8.47e-04 | 1370 | 153 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | 8.77e-04 | 415 | 153 | 10 | GSM791134_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3 | 9.61e-04 | 420 | 153 | 10 | GSM791136_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 9.81e-04 | 157 | 153 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K1 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 9.96e-04 | 422 | 153 | 10 | GSM399442_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | H1-10 KIF23 HIRIP3 RBBP6 ATAD5 KIF4A SOCS6 FREM2 FBN2 RBMX2 STAU2 RAI14 CLSPN TOP2A | 1.06e-03 | 749 | 153 | 14 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.10e-03 | 285 | 153 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.27e-03 | 165 | 153 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_500 | 1.29e-03 | 226 | 153 | 7 | Facebase_ST1_e10.5_MaxilArch_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 1.29e-03 | 437 | 153 | 10 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.49e-03 | 524 | 153 | 11 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | NOLC1 SETX HIRIP3 ZNF280C CKAP5 NCL RPL14 ATAD2 WARS2 LIG3 FBN2 NEMF EXO1 GALNT5 | 1.54e-03 | 779 | 153 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ELOA ARID4A RBBP6 NUMA1 NCL HP1BP3 CCDC66 BTBD7 TET1 MKI67 NKTR CLSPN SLX4 AFF4 | 1.56e-03 | 780 | 153 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 1.66e-03 | 376 | 153 | 9 | GSM538418_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 1.66e-03 | 304 | 153 | 8 | GSM538354_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.72e-03 | 378 | 153 | 9 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 1.80e-03 | 308 | 153 | 8 | GSM605775_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | NOLC1 H1-10 ZNF609 TCOF1 NHSL2 NCL HMGA1 PRAG1 CCDC71 XPNPEP3 H1-3 SF3A3 EXO1 SMARCC1 PDCD11 H1-1 CCDC86 GNL3 BAHCC1 | 1.81e-03 | 1259 | 153 | 19 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CUL4B NOLC1 SETX DLGAP5 ATAD2 TERF1 ESF1 SCML2 TET1 EXO1 NANOS3 PDCD11 CLSPN GNL3 | 1.86e-03 | 795 | 153 | 14 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B NOLC1 SETX DLGAP5 HMGA1 ATAD2 TERF1 SCML2 TET1 EXO1 NANOS3 PDCD11 CLSPN GNL3 | 1.95e-03 | 799 | 153 | 14 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.98e-03 | 463 | 153 | 10 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.99e-03 | 123 | 153 | 5 | gudmap_developingGonad_e12.5_epididymis_k4_1000 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 2.02e-03 | 74 | 153 | 4 | GSM538418_100 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | CUL4B NOLC1 EDF1 TCOF1 ATAD5 CKAP5 BMERB1 NCL HMGA1 ATAD2 ESF1 RBMX2 TET1 SF3A3 EXO1 SMARCC1 H1-1 CCDC86 TOP2A GNL3 | 2.04e-03 | 1371 | 153 | 20 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.06e-03 | 124 | 153 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | SOX4 KIF23 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 MKI67 EXO1 PDCD11 CLSPN TOP2A | 3.82e-13 | 199 | 159 | 13 | 38f1f612b29feb868322999ceeda78e52447ec4f |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | SOX4 KIF23 ATAD5 DLGAP5 TOPBP1 CKAP5 KIF4A ATAD2 MKI67 EXO1 PDCD11 CLSPN TOP2A | 3.82e-13 | 199 | 159 | 13 | b10698aee2e6c17bc559eb4f723024141f914b90 |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | KIF23 TCOF1 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 NUCKS1 H1-1 HADHA CLSPN TOP2A | 4.08e-13 | 200 | 159 | 13 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | KIF23 TCOF1 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 NUCKS1 H1-1 HADHA CLSPN TOP2A | 4.08e-13 | 200 | 159 | 13 | b46b2064362efc64edf19ab2b21bc89047c9d943 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SETX ARID4B NCL IFI16 SP110 CDK13 AHNAK NUFIP2 XRN1 NKTR DDX24 GOLGA8A AFF4 | 4.08e-13 | 200 | 159 | 13 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 4.08e-13 | 200 | 159 | 13 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 4.08e-13 | 200 | 159 | 13 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | H1-10 KIF23 HIRIP3 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 NUCKS1 H1-1 CLSPN TOP2A | 2.48e-12 | 180 | 159 | 12 | 5e1680088065be14447d5d5465f91f7edd071a1e |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A C13orf42 | 7.20e-12 | 197 | 159 | 12 | 4a4d3083938783d6f5b87da02f10e501917da0b4 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | EDF1 ARID4A RBBP6 ZC3H13 NCL ESF1 AHNAK NEMF NKTR CLSPN GOLGA8A TOP2A | 7.20e-12 | 197 | 159 | 12 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-NoSEP / Disease, condition lineage and cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 8.60e-12 | 200 | 159 | 12 | f70cc9198339eab7fbc68f5d9b75dfb28c9afc89 |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A HMGA1 ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 8.60e-12 | 200 | 159 | 12 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 4.74e-11 | 178 | 159 | 11 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | H1-10 KIF23 HIRIP3 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 5.03e-11 | 179 | 159 | 11 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 6.77e-11 | 184 | 159 | 11 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KIF23 HIRIP3 TCOF1 DLGAP5 CKAP5 KIF4A H1-3 MKI67 NUCKS1 CLSPN TOP2A | 6.77e-11 | 184 | 159 | 11 | 8f40093de5bb978f046d66e8f05f333686a009a4 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KIF23 HIRIP3 DLGAP5 CKAP5 KIF4A ATAD2 PRAG1 MKI67 NUCKS1 CLSPN TOP2A | 8.53e-11 | 188 | 159 | 11 | 95d0a796d62ce6d121e2028c378faffc14b35275 |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 H1-1 CLSPN TOP2A | 8.53e-11 | 188 | 159 | 11 | b240ea20750ffb825cb5fe41d06c632233406ab6 |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KIF23 HIRIP3 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 NUCKS1 H1-1 CLSPN TOP2A | 1.19e-10 | 194 | 159 | 11 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | KIF23 HIRIP3 DLGAP5 KIF4A NCL TERF1 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.26e-10 | 195 | 159 | 11 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A C13orf42 | 1.26e-10 | 195 | 159 | 11 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.26e-10 | 195 | 159 | 11 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KIF23 HIRIP3 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 NUCKS1 H1-1 CLSPN TOP2A | 1.33e-10 | 196 | 159 | 11 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | KIF23 HIRIP3 DLGAP5 KIF4A NCL TERF1 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.33e-10 | 196 | 159 | 11 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | KIF23 C19orf53 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | 41bdea47b9b1f6415a866a515d1535ea942fdede |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | KIF23 ATAD5 DLGAP5 KIF4A HMGA1 ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | d7a9296092153cf66426911fecd810f0c1ef978e |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | dcff23240bb7cb652d7426b29355aa74442ef6fc |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | 434a5686a103bb766e0d80038413f0e12ea3981a |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | c0a71a9452febda433bc544e4ac0a79c43dcf13e |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.41e-10 | 197 | 159 | 11 | f34b1e34f1f0694564031077172c890b233ce8b7 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A MKI67 EXO1 H1-1 CLSPN TOP2A | 1.49e-10 | 198 | 159 | 11 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | H1-10 KIF23 DLGAP5 KIF4A HMGA1 ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.49e-10 | 198 | 159 | 11 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | e8549b2c4152cb23548351d9cee27c3805892cd8 |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | ddae7fe7633661f15d3c79f5187415ffbfecce67 |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | HIRIP3 ATAD5 KIF4A HMGA1 ATAD2 H1-3 MKI67 NUCKS1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | 99778178e3ec121802db938db8c5475d19b43fec |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | fba48342066aab41a8bcb20db40a6df0158e1cbe |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | af78837f3a7641a5bd98765eef9cb4f86034048c |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.57e-10 | 199 | 159 | 11 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 HP1BP3 H1-3 MKI67 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 NUCKS1 H1-1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 14c9ced92763858f3d35186cd3908bd0f4cfd872 |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 535f6fba8d03873ba35c9949579161dc41cd7a60 |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 52265e761a961f3724b388285e0919bd58847138 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | KIF23 ATAD5 DLGAP5 KIF4A HMGA1 ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | fcd16d36f67abf154428242b398b71473f281758 |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 0892603e604c2a945dd720685d45970f855bd5d3 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 0675f580ccef705875854247bbfd4ee2bcf126a1 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type. | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 2ee167b8bddd11fd5b1f61f87fcdf757aee3193e |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 3e3de496508efb2f95e5e8684f97687381e96493 |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 60d11275f06490f86f400a2802492f9c1b570400 |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | KIF23 HIRIP3 ATAD5 DLGAP5 TOPBP1 KIF4A ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 4723613a9f56bff422fc98722128d57b6adf3c5d |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | KIF23 ATAD5 DLGAP5 KIF4A HMGA1 ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | b6a016132526e910f95bb40038bbb23f301ca023 |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | H1-10 ARID4B RBBP6 NCL SP110 CDK13 AHNAK H1-3 XRN1 DDX24 AFF4 | 1.65e-10 | 200 | 159 | 11 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 NUCKS1 H1-1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 NUCKS1 H1-1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 38665128b54f4a81b53c961427aed67bf4e2510b |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | KIF23 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 EXO1 H1-1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | d86119766b9c4f1570cd8045313345f9be46d431 |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 NUCKS1 CLSPN TOP2A | 1.65e-10 | 200 | 159 | 11 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-10 | 169 | 159 | 10 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-10 | 173 | 159 | 10 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-10 | 173 | 159 | 10 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE3A CKAP5 NSD1 BTBD7 AHNAK NUFIP2 XRN1 ELK4 HADHA ARHGAP21 | 8.37e-10 | 176 | 159 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | 10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 9.86e-10 | 179 | 159 | 10 | c93711273055a999335ba8d0f6500e4549f46cec |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A MKI67 H1-1 CLSPN TOP2A | 9.86e-10 | 179 | 159 | 10 | ac987c9425a1b4106d1b8779a2c5461383eae2ae |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.16e-09 | 182 | 159 | 10 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 1.22e-09 | 183 | 159 | 10 | a48a6313f2f144586951cece97ec31f6d72361df |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-09 | 185 | 159 | 10 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-09 | 186 | 159 | 10 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-09 | 186 | 159 | 10 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | KIF23 HIRIP3 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 MKI67 CLSPN TOP2A | 1.59e-09 | 188 | 159 | 10 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-09 | 189 | 159 | 10 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-09 | 189 | 159 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-09 | 190 | 159 | 10 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 H1-3 MKI67 CLSPN TOP2A | 1.76e-09 | 190 | 159 | 10 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | KIF23 ATAD5 DLGAP5 CKAP5 KIF4A ATAD2 HP1BP3 EXO1 CLSPN TOP2A | 1.76e-09 | 190 | 159 | 10 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-09 | 190 | 159 | 10 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | KIF23 ATAD5 DLGAP5 KIF4A PTPN22 ATAD2 MKI67 EXO1 CLSPN TOP2A | 1.85e-09 | 191 | 159 | 10 | bae388e0e9447d576e68465d73d8313ef6925ffa |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | KIF23 DLGAP5 CKAP5 KIF4A ATAD2 H1-3 MKI67 NUCKS1 CLSPN TOP2A | 1.85e-09 | 191 | 159 | 10 | a3c5a913a99f17633c140ec9ece81b73e59e0715 |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | H1-10 KIF23 HIRIP3 DLGAP5 KIF4A ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 1.95e-09 | 192 | 159 | 10 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-09 | 192 | 159 | 10 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF23 HIRIP3 TCOF1 DLGAP5 KIF4A ATAD2 MKI67 NUCKS1 CLSPN TOP2A | 2.05e-09 | 193 | 159 | 10 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | KIF23 HIRIP3 DLGAP5 KIF4A HMGA1 ATAD2 H1-3 MKI67 CLSPN TOP2A | 2.05e-09 | 193 | 159 | 10 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-09 | 193 | 159 | 10 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.15e-09 | 194 | 159 | 10 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.15e-09 | 194 | 159 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | KIF23 HIRIP3 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 CLSPN TOP2A | 2.15e-09 | 194 | 159 | 10 | 9bbb124001fba7450f4639f47f9b720a483e7242 |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-09 | 194 | 159 | 10 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | 356C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-09 | 195 | 159 | 10 | ba8b8831bd5f544f4e25f13949d04e164ecdcd12 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.26e-09 | 195 | 159 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| Computational | rRNA processing and DNA repair. | 1.40e-05 | 18 | 92 | 4 | MODULE_392 | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.89e-07 | 176 | 151 | 10 | 958_DN | |
| Drug | GV | 1.68e-06 | 123 | 151 | 8 | CID005466602 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.18e-06 | 179 | 151 | 9 | 4585_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.46e-05 | 177 | 151 | 8 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.56e-05 | 178 | 151 | 8 | 3998_DN | |
| Drug | testosterone enanthate | SOX4 ELOA PDE3A TCOF1 GBP2 IFI16 SP110 ESF1 NKTR HADHA PARD3 DDX24 CEP57 TBX1 | 3.04e-05 | 575 | 151 | 14 | ctd:C004648 |
| Drug | CPG-oligonucleotide | 3.24e-05 | 184 | 151 | 8 | ctd:C408982 | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.37e-05 | 185 | 151 | 8 | 1673_DN | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.64e-05 | 187 | 151 | 8 | 5023_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.78e-05 | 188 | 151 | 8 | 6735_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A | 3.93e-05 | 189 | 151 | 8 | 1742_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.93e-05 | 189 | 151 | 8 | 1045_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 3.93e-05 | 189 | 151 | 8 | 1171_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A | 4.08e-05 | 190 | 151 | 8 | 1974_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 4.08e-05 | 190 | 151 | 8 | 4307_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.23e-05 | 191 | 151 | 8 | 5204_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | 4.39e-05 | 192 | 151 | 8 | 6659_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.55e-05 | 193 | 151 | 8 | 5239_DN | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; HL60; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 2965_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 4312_DN | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 4.90e-05 | 195 | 151 | 8 | 944_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A | 5.08e-05 | 196 | 151 | 8 | 1958_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HG-U133A | 5.08e-05 | 196 | 151 | 8 | 1906_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 1224_DN | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 5778_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 3444_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 7262_DN | |
| Drug | Dasatinib | SOX4 PDE3A KIF23 ATAD5 DLGAP5 KIF4A ATAD2 MKI67 EXO1 H1-1 CLSPN TOP2A | 8.58e-05 | 478 | 151 | 12 | ctd:D000069439 |
| Drug | Lucanthone | 8.80e-05 | 212 | 151 | 8 | ctd:D008154 | |
| Drug | torcetrapib | SETX ARID4B RBBP6 AASDHPPT IFI16 WARS2 DUSP16 H1-3 SMARCC1 PIP4K2B | 9.89e-05 | 342 | 151 | 10 | ctd:C483909 |
| Drug | 4-PBA | 1.29e-04 | 224 | 151 | 8 | CID000004775 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.65e-04 | 174 | 151 | 7 | 1302_UP | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.84e-04 | 177 | 151 | 7 | 841_DN | |
| Drug | phosphoramide mustard | 1.88e-04 | 43 | 151 | 4 | ctd:C030090 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.97e-04 | 179 | 151 | 7 | 5822_DN | |
| Drug | 5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 1.97e-04 | 179 | 151 | 7 | 904_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.04e-04 | 180 | 151 | 7 | 6886_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.18e-04 | 182 | 151 | 7 | 1043_DN | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | SOX4 HIRIP3 SASH1 DLGAP5 TOPBP1 CKAP5 BMERB1 GBP2 HMGA1 ATAD2 PHF20L1 NOM1 MKI67 EXO1 CEP57 TOP2A AFF4 | 2.23e-04 | 961 | 151 | 17 | ctd:C029497 |
| Drug | 3-hydroxyisovaleric acid | 2.24e-04 | 45 | 151 | 4 | CID000069362 | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.49e-04 | 186 | 151 | 7 | 5777_DN | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.57e-04 | 187 | 151 | 7 | 3075_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.57e-04 | 187 | 151 | 7 | 4323_DN | |
| Drug | diafenthiuron | 2.60e-04 | 4 | 151 | 2 | CID003034380 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 2.66e-04 | 188 | 151 | 7 | 4310_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 4304_DN | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 3690_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 3214_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.74e-04 | 189 | 151 | 7 | 5084_DN | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 2.83e-04 | 190 | 151 | 7 | 622_DN | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.83e-04 | 190 | 151 | 7 | 3297_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.83e-04 | 190 | 151 | 7 | 4306_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.83e-04 | 190 | 151 | 7 | 1074_DN | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; HL60; HT_HG-U133A | 2.83e-04 | 190 | 151 | 7 | 2456_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 4303_DN | |
| Drug | Latex | 2.92e-04 | 191 | 151 | 7 | ctd:D007840 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 4283_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.92e-04 | 191 | 151 | 7 | 6644_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.02e-04 | 192 | 151 | 7 | 7176_DN | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A | 3.02e-04 | 192 | 151 | 7 | 3054_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.11e-04 | 193 | 151 | 7 | 1081_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.11e-04 | 193 | 151 | 7 | 4846_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.11e-04 | 193 | 151 | 7 | 4305_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | 3.11e-04 | 193 | 151 | 7 | 2563_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 1822_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 4309_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; HL60; HG-U133A | 3.21e-04 | 194 | 151 | 7 | 1552_DN | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 1166_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.21e-04 | 194 | 151 | 7 | 4361_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | 3.21e-04 | 194 | 151 | 7 | 1741_DN | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 3.31e-04 | 195 | 151 | 7 | 1138_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 3559_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 5571_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 4481_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 6614_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A | 3.31e-04 | 195 | 151 | 7 | 632_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 3.31e-04 | 195 | 151 | 7 | 6159_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 3040_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 3.42e-04 | 196 | 151 | 7 | 1558_DN | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 7139_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 4416_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 4524_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 3256_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 3.42e-04 | 196 | 151 | 7 | 2036_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.42e-04 | 196 | 151 | 7 | 4711_DN | |
| Drug | nocodazole | KIF23 MAP6 RBBP6 DLGAP5 NUMA1 NCL TERF1 FBN2 CDK13 NOM1 CEP57 | 3.52e-04 | 477 | 151 | 11 | CID000004122 |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 5819_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 2559_DN | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; PC3; HG-U133A | 3.52e-04 | 197 | 151 | 7 | 1947_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 4847_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 3019_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 4476_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 6222_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; HL60; HG-U133A | 3.52e-04 | 197 | 151 | 7 | 1388_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 7146_DN | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 3.52e-04 | 197 | 151 | 7 | 7352_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.63e-04 | 198 | 151 | 7 | 3730_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 3.63e-04 | 198 | 151 | 7 | 2060_UP | |
| Drug | colcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA | 3.63e-04 | 198 | 151 | 7 | 1103_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 3.63e-04 | 198 | 151 | 7 | 1609_DN | |
| Disease | Adenoid Cystic Carcinoma | 1.08e-05 | 100 | 146 | 6 | C0010606 | |
| Disease | seropositivity measurement, Chlamydia pneumoniae seropositivity | 7.27e-05 | 3 | 146 | 2 | EFO_0007034, EFO_0007035 | |
| Disease | sleep efficiency | 2.41e-04 | 5 | 146 | 2 | EFO_0803364 | |
| Disease | glycoprotein measurement | 3.22e-04 | 119 | 146 | 5 | EFO_0004555 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 3.60e-04 | 6 | 146 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | pain | 4.47e-04 | 196 | 146 | 6 | EFO_0003843 | |
| Disease | Uterine leiomyoma, breast carcinoma | 5.30e-04 | 32 | 146 | 3 | EFO_0000305, HP_0000131 | |
| Disease | protein CREG1 measurement | 8.56e-04 | 9 | 146 | 2 | EFO_0801937 | |
| Disease | Liver carcinoma | 9.85e-04 | 507 | 146 | 9 | C2239176 | |
| Disease | Childhood Medulloblastoma | 1.27e-03 | 43 | 146 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.27e-03 | 43 | 146 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.27e-03 | 43 | 146 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.27e-03 | 43 | 146 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.27e-03 | 43 | 146 | 3 | C0278876 | |
| Disease | type 1 diabetes mellitus | 1.33e-03 | 242 | 146 | 6 | MONDO_0005147 | |
| Disease | QT interval | 1.41e-03 | 534 | 146 | 9 | EFO_0004682 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 1.96e-03 | 50 | 146 | 3 | C0025149 | |
| Disease | alopecia areata | 1.96e-03 | 50 | 146 | 3 | EFO_0004192 | |
| Disease | body weights and measures, body height | 2.45e-03 | 15 | 146 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | graft-versus-host disease (is_implicated_in) | 3.15e-03 | 17 | 146 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 3.31e-03 | 123 | 146 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.53e-03 | 18 | 146 | 2 | EFO_1000649, HP_0000131 | |
| Disease | autoimmune thyroid disease, type 1 diabetes mellitus | 3.53e-03 | 18 | 146 | 2 | EFO_0006812, MONDO_0005147 | |
| Disease | autoimmune thyroid disease | 3.61e-03 | 126 | 146 | 4 | EFO_0006812 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.93e-03 | 19 | 146 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | sucrose liking measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0010157 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSFSPNTGKKNAKIK | 101 | P21796 | |
| PVAKTRAKAKAKTGS | 36 | Q6PI77 | |
| SSNLRKSGLKKPVVA | 326 | Q9NWW7 | |
| KSGLKKPVVASSLKR | 331 | Q9NWW7 | |
| RAKAKLSKFSIPKQG | 276 | P51826 | |
| TTDKSSKPQIKRGKR | 811 | Q4LE39 | |
| SKARDKGNNPETKKS | 1611 | Q96QE3 | |
| PAKSVLKSAEGKRTK | 121 | Q5U5X8 | |
| GPSSSSKSKLKRKEA | 2436 | Q9P281 | |
| QRKPFSASGKKQAAK | 641 | Q15059 | |
| SGQLSSSKKPARKEK | 676 | Q15059 | |
| RTAKGKPVLAKDSSN | 86 | Q9NRN7 | |
| AKKRKGSSSQAPASK | 211 | Q9H6F5 | |
| KQKRTPKRTSAAAKN | 1086 | P29374 | |
| NKKASSVETKPGASK | 111 | Q02539 | |
| QAKAKGSKSPSAGRK | 1836 | Q96L96 | |
| PLAKQVSSRGGKSKK | 331 | Q86XR8 | |
| SKKKSAPSILSNGRI | 251 | Q8NDD1 | |
| KPKACKKDLGSSRQI | 261 | A0A1B0GVH6 | |
| VSGPKLNIEGKSKKS | 3336 | Q09666 | |
| KSGTVSSQKKPALKA | 421 | Q8N2N9 | |
| SQVKPSLKSTKASKG | 1256 | Q9ULJ7 | |
| SAGAAQKKPAATTAK | 41 | Q6PL18 | |
| PSSGGTLKNDKAKTK | 526 | Q14004 | |
| KLRNSAKGKVPKSAL | 46 | Q86WX3 | |
| KGSRKPNIKKESKSS | 606 | Q9UHB7 | |
| KAKTPAKKTRPSSTV | 501 | Q5SSJ5 | |
| NSAGKKLVRPDKAKT | 126 | P60323 | |
| KISSERSGTPKKRKA | 261 | Q9P0K7 | |
| KSSDNPKRTSVKKGH | 501 | Q96L73 | |
| NGPVAKKAKKKASSS | 71 | Q14978 | |
| GPKKHSSKNSERAQK | 201 | Q9Y388 | |
| KQTLKTPGKSFTRSK | 736 | Q9Y2R2 | |
| PKRRKSSKSSGKAVF | 76 | Q8N9R6 | |
| KGKVGRPTASKASKE | 186 | Q9H1E3 | |
| AAPAAKTRKQAAKKV | 721 | Q8IYF1 | |
| KKPGTSVKVSCKASG | 31 | A0A0C4DH39 | |
| KSSKPTASKVKNGAA | 261 | Q8IZA3 | |
| TASKVKNGAASPTKK | 266 | Q8IZA3 | |
| RKAGLPIKASSSKVS | 326 | Q8IZA3 | |
| VVKKQAPGKASVSRK | 176 | Q9BW71 | |
| QKKSAGRSRSALKKP | 51 | O15480 | |
| VAATRPKTTKSGKAL | 281 | Q96JG8 | |
| KSRGRSASPKKQQKI | 1281 | Q5TCQ9 | |
| SASPKKQQKIEGSKA | 1286 | Q5TCQ9 | |
| HKPTRKAKDKQAVSG | 391 | Q96JE9 | |
| QAAKKKSAEGPSTTK | 406 | Q96JE9 | |
| TPGVQKKGKAAKTAL | 1016 | O60524 | |
| KSDGKPRKVRFKISS | 11 | A6NFK2 | |
| GSAALSPSKKRKNSK | 26 | Q92522 | |
| KKPGASVKVSCKASG | 31 | P01743 | |
| KVTKSPASSRAEKKA | 161 | Q96MC5 | |
| GKPQSTTKSRKKREI | 3041 | Q5SZK8 | |
| KAPAKKKGAAAATSS | 81 | Q9UNZ5 | |
| PSNSKVLVSGKRKDK | 921 | Q5VYM1 | |
| INKKSVKSAKDGTSP | 681 | Q9H501 | |
| KKPGASVKVSCKVSG | 31 | A0A0C4DH33 | |
| KKPGASVKVSCKASG | 31 | P0DP01 | |
| VLRKKGPTAAQAKSK | 11 | O60869 | |
| AKAAATQKKVERKAP | 76 | P02675 | |
| LSKNGKTKKGNRVSP | 181 | P08620 | |
| SARKKNLSGFSPRKK | 666 | Q9Y468 | |
| KAKKQSRPGALAKIS | 506 | Q14432 | |
| IPKGSKTTAAKKESL | 506 | Q8IVL0 | |
| KNKQKTSGTRKGFPR | 506 | Q8N8W4 | |
| LRKGTDKKSKSFNDP | 206 | P32456 | |
| NPSVGTAASDTKKKK | 26 | H0YM25 | |
| CVVGKAKKPRSFKST | 226 | Q9Y4A0 | |
| ASVTGSKRHPKTKEK | 1446 | P46013 | |
| KKPGATVKISCKVSG | 31 | A0A0G2JMI3 | |
| IADLSSKAAGTPKKK | 181 | P49916 | |
| SKAAGTPKKKAVVQA | 186 | P49916 | |
| KSSPVKVGEKRKAAD | 911 | P49916 | |
| KKPGASVKVSCKASG | 31 | P23083 | |
| GERSKPKRQKSSTKL | 461 | O94988 | |
| KKPGASVKVSCKASG | 31 | A0A0C4DH29 | |
| KKPGASVKVSCKASG | 31 | A0A0C4DH31 | |
| VVIPQKKGKKAAATS | 46 | P19338 | |
| SGTKSRPAKKKSSPV | 101 | P32242 | |
| SAVSKKENIVKPAKG | 1026 | Q7Z6E9 | |
| SEPALNIKKSGKSFK | 11 | A0A1B0GVM5 | |
| KKPGASVKVSCKASG | 31 | A0A0J9YVY3 | |
| RLKKQNTVSKGPFSK | 341 | Q92794 | |
| SKANIESKRPKAKSV | 771 | Q9UKF2 | |
| KAKAPGLSSKAKSAQ | 1126 | Q14008 | |
| PKGSAKARTTRKGQK | 366 | Q8IV32 | |
| LSKKIPGNSNFVKSK | 126 | Q14410 | |
| DKVNNSSRSKKPKGL | 311 | P28324 | |
| KTPEGKVKTNLDRKS | 396 | Q14241 | |
| SKTKTIFPKVLGKSQ | 341 | Q7Z7M9 | |
| TKKRKLGKNPDVDTS | 151 | Q14320 | |
| AKKKAKSDPGIQSTS | 316 | Q8TAL5 | |
| KKIKNQTGASGPKSK | 296 | Q9BY84 | |
| PILKKDSKARTKSGS | 436 | Q9HC77 | |
| GNKAKIAKCPLRTKT | 36 | A2RUB6 | |
| INTAKIKGKNSFAPK | 296 | Q15398 | |
| RKKVVSGIASKPKQD | 551 | Q15398 | |
| SKSPVKKKSFVQVGG | 411 | Q9UQ52 | |
| EKPQDKKKRTSGLAT | 51 | Q9P203 | |
| EATPGAQKRKKSTKE | 121 | Q16666 | |
| KNKGKKGLEPSQSTA | 156 | Q9GZR7 | |
| TFAKGLADKKISPKR | 246 | P40939 | |
| TVVFRASTKPKDKGK | 201 | Q9BVP2 | |
| PGKKKKRALASNTSF | 1206 | O95239 | |
| GKCSVPKAFNTTKAK | 2111 | P35556 | |
| ATQKKKPDGFSSRSK | 181 | A8MQT2 | |
| KPATAAGTKKVAKSA | 161 | P16402 | |
| SVRDKSPVKKAKATA | 191 | Q86SE8 | |
| QAKKTGAKPSQARKV | 336 | Q8NCQ7 | |
| GAKPSQARKVNKRKS | 341 | Q8NCQ7 | |
| FANSKPGSAKKLVIK | 186 | Q13620 | |
| QHGSSKGKSPSRNKK | 1286 | Q15648 | |
| KGKSPSRNKKPSLTA | 1291 | Q15648 | |
| APKSKINCRKSTTGK | 161 | Q3MIW9 | |
| RGASKKALSKASPNT | 2066 | Q14980 | |
| KQNTAGSPKTCDRKK | 181 | Q8TEW0 | |
| PKGSKNKGAAKTRKT | 61 | P17096 | |
| AKTPRKPTVKKGSQT | 6 | Q02241 | |
| AAAKNKTGSKPRTSA | 181 | A8MW92 | |
| QKKKPDGFSSRSKAL | 211 | A7E2F4 | |
| KGSAAAPALQKDSKK | 21 | Q9UGM6 | |
| SKPAQKKSCGSKVAG | 191 | Q06945 | |
| PAKAKEAGKRKSSSQ | 11 | Q9H321 | |
| PAKAKETGKRKSSSQ | 11 | O14598 | |
| NPIFKSRSKKRKGSD | 886 | O75151 | |
| KTVANLLSGKSPRKS | 146 | Q13428 | |
| FKALLQKKGSKATPR | 1176 | Q5HYW2 | |
| DQKPSVSKSGRKIKG | 321 | P30414 | |
| KLRKQAASPKGASVS | 596 | Q9BXS9 | |
| VAVAPLSASKTKTKK | 11 | P78356 | |
| TPKKTHSDAKKGQNR | 1241 | Q7Z333 | |
| PSRVKAKATAATAKT | 146 | Q5C9Z4 | |
| NKRKKKDGSSSVPLS | 196 | Q5C9Z4 | |
| QEVSSTPSDKKGKKR | 266 | Q9HB58 | |
| PTESRKKSGKKGQAS | 336 | Q92922 | |
| ARASGLSKKPASIQK | 761 | Q9UQ84 | |
| ANARGKSKAKAKAPA | 81 | Q8NEG4 | |
| KPKDRATNSKATTPK | 1006 | Q92954 | |
| SIGAKSKTPKNREKG | 1011 | Q96KW2 | |
| NTLVGSASSKKAKKP | 81 | Q6Q759 | |
| SASSKKAKKPVGGNA | 86 | Q6Q759 | |
| TATKTKTLQGPAEKK | 96 | Q8IY92 | |
| KNVASVKTLSPGKLK | 36 | Q8NFU7 | |
| KKPSAASTGQKRKVA | 6 | Q12798 | |
| AKESSKSQVKKRGPS | 1296 | Q9HAW4 | |
| KAGATTKGKSQSKEP | 31 | Q8WUR7 | |
| GKPASAATVKRKRKS | 371 | Q8IWZ8 | |
| AKNSKAAGGPKLTKR | 1766 | O15417 | |
| SGSEQERVSKKPKKA | 1476 | Q14690 | |
| RKSSDSKPGVSSKKF | 301 | Q7Z417 | |
| ATGTGPNKKIAKKNA | 351 | Q9NUL3 | |
| AAAAKVPAKKITAAS | 156 | P50914 | |
| KRSSSVKNITPRKKG | 296 | Q9UQR0 | |
| ESTANKKSKARPKSG | 706 | O15066 | |
| KNKPTAIVAKTFKGR | 236 | Q9H0I9 | |
| SKAKKPSQFSGKITV | 396 | Q92545 | |
| PSQFSGKITVKAKEK | 401 | Q92545 | |
| PQGKEGKSKSKRSKS | 81 | O15014 | |
| KSRKLAVNFGVSKPS | 1691 | Q8IZH2 | |
| KSPTASRISLGKKVK | 441 | O94885 | |
| RVGTPQSTKKKKESR | 341 | P54274 | |
| KGKAVRTPEKQKSSL | 191 | Q147U7 | |
| STKRKKAAPVPSKSQ | 416 | Q86YV5 | |
| SKPQTEGKKASKSRL | 711 | Q92543 | |
| GTKTKKQTTLAFKPI | 1271 | P11388 | |
| PLTEAKAKSKNKVRG | 221 | Q9NQH7 | |
| FAKNPKSKGTKRDTE | 301 | Q12874 | |
| NTSKPRGRIAKSKAK | 576 | Q8ND82 | |
| LKKKTPRVKSCGEVS | 26 | Q96I27 | |
| AAKAPVKKNAKVAGV | 96 | O43435 | |
| SADGPAKKKVAKVTV | 66 | Q01831 | |
| SATAKGKKPSKERLT | 326 | Q01831 | |
| GNKTRSCKAPKVVRK | 191 | P0DMS9 | |
| RFPGKSVNSKLSIKK | 306 | Q9NUQ2 | |
| SSIFAAASRKRKKPK | 1411 | Q5T5U3 | |
| TGLSQKRKAPTEKNK | 1501 | Q92547 | |
| LSAKQKSKGKAGTPS | 81 | O14544 | |
| SGLIISKKNCSRKKP | 151 | Q8NDW4 | |
| SKTNQSKKKGPRTPS | 251 | Q5T200 | |
| PVSKAKQSRSEKKAR | 1926 | E9PAV3 |